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PREFACE1
     The main function of the lung is gas exchange of oxygen and carbon
dioxide. The gas exchange occurs in alveolar airspace and capillary blood
vessels on the basolateral surface of alveoli. The alveolar epithelium is mainly
composed of type I and type II alveolar epithelial cells (AEC I and AEC II).
During inspiration and respiration, oxygen diffuses from alveolar airspace to
capillary blood vessels, and carbon dioxide in an opposite direction driven by
gas concentration gradients. Therefore, the knowledge of AEC I and AEC II is
essential for the understanding of gas exchange and related lung diseases
(e.g. lung injury induced by hyperoxia or air pollutants).
     Currently, the functions of alveolar epithelial cells, especially AEC I are
not well understood. AEC I are squamous and cover about 93% of alveolar
surface. A number of AEC I marker genes were identified, including caveolin,
T1 alpha, and aquaporin 5, but their functions in AEC I are not clear. Due to
their large surface area, AEC I form a barrier, through which oxygen and
carbon dioxide exchange. AEC I are believed to be terminally differentiated,
and thus can not regenerate themselves. Compared with AEC I, AEC II are
better understood, due to the fact that AEC II are easier to be isolated from the
lung and studied in vitro. They are small and cuboidal, covering about 7%
surface of alveoli. Various markers were identified in AEC II, including
1 Only the most relevant references are listed herein. All other references in this section can be found
in the following chapters.
iv
surfactant proteins and LB180. Surfactant proteins A, B, C and D are proteins
secreted by AEC II, and play roles in host defense and the formation of
lipid-protein lattices, which prevent alveoli collapsing during inspiration and
respiration. LB180 is important for cholesterol transport. AEC II are able to
proliferate and differentiate, and are believed to be the progenitors of type I
cells.  However, the proliferation and differentiation are poorly understood.
     Based on cellular kinetics studies of AEC, a model of AEC II
differentiation was proposed over ten years ago (1). According to this model,
most AEC II in normal lung are in resting status, G0 phase. In case of lung
injury or mitogenic stimulation, a portion of AEC II can be activated by growth
factors through MAPK signaling pathway.  KGF (FGF7) is one of the growth
factors that are known to be required for AEC II proliferation and differentiation.
Activated AEC II enter cell cycle and divide into daughter cells, which
subsequently differentiate to AEC I and AEC II. Mature AEC I irreversibly lose
mitogenic ability. However, it is not clear how this process occurs. Many
genes, such as transcription factors, have been studied in AEC II
differentiation since the proposing of the model, but the mechanisms involved
are not completely understood (2). Furthermore, the proposed model can not
explain how AEC markers, surfactant proteins and T1 , are differentially
expressed in AEC I or AEC II.
The poor understanding of AEC differentiation is partially resulted from
two fundamental problems, experimental cell differentiation models and gene
study tools. There are in vivo (fetal lung development, hyperoxia, and hypoxia)
and in vitro (AEC II culture) models, but none of them is effective. The limits
behind in vivo the cell differentiation models are the complex of cell-cell
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interaction, because there are over 40 cell types in the lung. Therefore, it is
difficult to identify the factors controlling AEC II proliferation and differentiation
from the interaction between AEC II and the other cell types in the lung. The in
vitro AEC II culture has been used as a trans-differentiation model. AEC II lose
surfactant proteins and the cuboidal shape, and gain T1  and “AEC I-like”
squamous shape during culture in plastic dishes. This in vitro differentiation
may be different from in vivo AEC II differentiation, due to the artifacts of
culture environment, which is different from the lung alveoli. A common
approach for AEC II differentiation is the combination of in vivo and in vitro
models to eliminate the in vivo complex and in vitro artifacts. The second
fundamental problem is gene study tools. In the past, individual genes were
studied in AEC II differentiation, including the components of signaling
pathways (e.g. KGF, IGF, ERK, MAPK and Bmp4), transcription factors (HNF,
ssh and NF-kappaB), hormone (glucocorticoid) or cell proliferation control (e.g.
p53 and rb). However, very few AEC-specific proliferation or differentiation
genes have been identified. It is unclear if AEC II differentiation is controlled by
a group of common genes or by some AEC-specific genes.
     Facing with the two fundamental problems, I investigate AEC
differentiation step by step in this dissertation. First, AEC differentiation models
are developed and improved. An in vitro model with highly pure AEC II
(Chapters 1, 4 and 5) and an in vivo hyperoxia model (Chapters 4 and 5) are
developed for cell differentiation. In both models, a purity (about 95% for AEC
II and 90% for AEC I) higher than previously reported results are achieved with
modified cell isolation methods, and thus AEC-specific genes for cell
differentiation can be identified. Second, high throughput gene study tools
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based on DNA microarray are developed to identify genes involved in AEC II
differentiation. A DNA microarray is a slide containing thousands of DNA
probes, which capture fluorescently labeled cDNA from one or two biological
samples (3). DNA microarray slides with 10,000 DNA probes are printed for
the hybridization with 6 parallel samples, and tested by the identification of
lung-prominent genes (Chapter 3). To increase the reliability of results from the
data generated by DNA microarray hybridization, a bioinformatics software
package, RealSpot, is written (Chapter 2).  Last, the cell differentiation
models and DNA microarray tools are applied to identify AEC-specific genes
(Chapters 1 and 3), and AEC differentiation genes and pathways (Chapter 5).
The results from this dissertation provide both biological understanding
of the lung, and technical tools for further study. Biologically, the Chapters 1 to
5 in this dissertation reveal clues of pulmonary functions from lung prominent
genes, a novel AEC I function from AEC I-specific genes, and a fine-tuning
model for balancing AEC II proliferation and differentiation. The biological
knowledge will help to understand lung injury and repair during hyperoxia
exposure, as well as other pathological conditions (e.g. asthma and edema).
Technically, the improved AEC isolation methods and DNA microarray tools
will be helpful for more detailed studies of AEC differentiation and functions of
identified genes in AEC.
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Identification of Two Novel Markers for
Alveolar Epithelial Type I and II Cells1,2
1.1  Abstract
Alveolar epithelial type I and type II cells (AEC I and II) are closely
aligned in alveolar surface. There is much interest in the precise identification
of AEC I and II in order to separate and evaluate functional and other
properties of these two cells. This study aims to identify specific AEC I and
AEC II cell markers by DNA microarray using the in vitro trans-differentiation of
AEC II into AEC I-like cells as a model. Quantitative real time PCR confirmed
five AEC I genes: fibroblast growth factor receptor-activating protein 1,
aquaporin 5, purinergic receptor P2X 7 (P2X7), interferon-induced protein, and
Bcl2-associated protein, and one AEC II gene: gamma-aminobutyric acid
receptor pi subunit (GABRP). Immunostaining on cultured cells and rat lung
tissue indicated that GABRP and P2X7 proteins were specifically expressed in
AEC II and AEC I, respectively. In situ hybridization of rat lung tissue confirmed
the localization of GABRP mRNA in type II cells. P2X7 and GABRP identified
1 Reprinted from Biochem Biophys Res Commun, 319, Zhongming Chen, Nili Jin, Telugu
Narasaraju, Jiwang Chen, Lucas R. McFarland, Mary Scott and Lin Liu, Identification of Two
Novel Markers for Alveolar Epithelial Type I and II Cells, 774-80, Copyright (2004), with
permission from Elsevier.
2 Contributions of co-authors: Nili Jin, Lucas R. McFarland, Mary Scott performed real-time
PCR; Telugu Narasaraju performed immunohistochemistry; Jiwang Chen performed in situ
hybridization. Lin Liu is the principal investigator.
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in this study could be used as potential AEC I and AEC II markers for studying
lung epithelial cell biology and monitoring lung injury.
1.2  Introduction
Alveoli are the gas exchange units of the lung. The alveolar epithelium
adapts to this functional role by developing two highly specialized alveolar
epithelial cells, cuboidal type II (AEC II) and squamous type I (AEC I). AEC II
consists of about 15% of the distal lung cells and occupies 5% of the alveolar
surface. AEC II synthesize and secrete lung surfactant, a protein-lipid complex
and surface-active material. Lung surfactant stabilizes alveoli by reducing the
surface tension. AEC II also maintain the alveolar epithelium by cell
proliferation and differentiation, minimize alveolar fluid by transport of sodium
from the apical to the basolateral side, and alter the inflammatory process by
the secretion of growth factors and cytokines. Surfactant proteins (SP)- A, B, C
and D [1;2], and Maclura pomifera lectin [3] have been used as markers of
AEC II. Recently, an apical membrane marker of AEC II and a lamellar body
limiting membrane marker have also been identified [4;5].
AEC I contribute 7% of total lung cells and covers over 95% of the
alveolar surface. This thin epithelium allows the easy diffusion of gases and
forms a barrier against the indiscriminate leakage of fluid into alveolar spaces.
It also regulates the exchange of physiologically important solutes and water
between circulating blood and the alveolar space. Recent studies indicated the
presence of sodium channel in AEC I, implying a role in fluid transport [6;7].
AEC I are terminally differentiated, lack mitotic activity, and are easily injured.
When the lung is injured, AEC II proliferate and differentiate to AEC I to repair
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the damaged alveolar epithelium. AEC I can be identified with marker genes
including AQP-5 [8], caveolin-1 [9], and T1 α [10;11].
AEC I and II are closely aligned in alveolar surface and are difficult to
separate for evaluating functional and other properties of the two epithelial
cells. Cell markers for the precise identification of these cells are not only
important for alveolar epithelial cell biology, but also could be used as
biochemical markers for lung injury. In this study, we screened the genes
differentially expressed in AEC I and AEC II using an in vitro culture model and
a DNA microarray containing 1090 rat genes. We verified several genes that
are specifically expressed in AEC I and AEC II using quantitative real time
PCR. Two of the selected genes were also studied in cultured cells and lung
tissue.
1.3  Materials and Methods
1.3.1 Materials
TRI reagents were from Molecular Research Center (Cincinnati, OH).
DNA-free™ kit was from Ambion (Austin, TX). Atlas™ Glass Fluorescent
Labeling kit and Glass™ Rat 1.0 microarray were from Clontech Laboratories
(Palo Alto, CA). Cyanine fluorescence dyes, Cy3 and Cy5 were from
Amersham-Pharmacia (Piscataway, NJ). QuantiTect™ SYBR® Green PCR kit
was from Qiagen (Valencia, CA). GENECLEAN Turbo for PCR was from
Qbiogene (Carlsbad, CA). Polyclonal goat anti-gamma-aminobutyric acid
receptor pi subunit (anti-GABRP) and anti-purinergic receptor P2X 7
(anti-P2X7) antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Monoclonal anti-LB180 antibodies were from Covance (Richmond CA).
Monoclonal anti-T1α (E11) antibodies were a generous gift from Dr. Antoinette
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Wetterwald (University of Berne, Switzerland) and Dr. Mary C. Williams
(Boston University). FITC-conjugated anti-goat IgG and Cy3-conjugated
anti-mouse IgG were from Jackson ImmunoRes (West Grove, PA).
1.3.2  Cell isolation and culture
AEC II were isolated from male Sprague-Dawley rats (180-200 grams)
according to the method of Dobbs et al. [12] as previously described [13]. The
isolated AEC II (5 x 106) were cultured in 100-mm plastic culture dishes
containing MEM plus 10% FBS for 1-7 days. Total RNA was isolated from
cultured cells using TRI reagents. The trace amount of genomic DNA
contamination in the RNA samples was digested with 2U DNase I at 370C for
30 minutes using the DNA-free™ kit. The quality of RNA was assessed by
A260/A280, agarose gel electrophoresis, and DNA contamination by PCR
directly using RNA sample and primers of SP-A.
1.3.3 RNA labeling and DNA microarray hybridization
The RNA samples were labeled using the Atlas™ Glass Fluorescent
Labeling kit. Because of difficulties in isolating AEC I cell preparation, we
chose in vitro culture of isolated AEC II as a model of AEC I. It is well
established that AEC II converts to AEC I-like cells when cultured on plastic
dishes for 7 days [11;14]. In the present study, we chose 1-day and 7-day
culture on plastics of isolated type II cells to represent AEC II and AEC I,
respectively, for the microarray experiments. We used “AEC II” and “AEC I” for
the 1-day and 7-day culture of AEC II in the rest of text. Two hybridizations
were performed using independent RNA preparations, each pooled from two
independent cell preparations. Briefly, 20 µg of total RNA isolated from “AEC
II” an “AEC I” were reverse-transcribed into cDNA with the incorporation of
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aminoallyl-dUTP (aa-dUTP), followed by the Cy3 or Cy5 coupling reaction.
The labeled cDNAs were incubated with an Atlas Glass™ Rat 1.0 microarray
at 500C overnight using the hybridization buffer and chamber provided with the
kit. After hybridization, the microarray slide was washed and scanned with
ScanArray 3000 (Packard BioChip Technologies, Billerica, MA).
1.3.4 Data analysis
 The hybridization images of DNA microarray were analyzed with the
software GenePix Pro 4.0 (Axon Instruments, Union City, CA), which provides
fluorescence intensity, standard deviation, and pixels of each spot and its
adjacent background area. The raw data were imported into Microsoft™ Excel
worksheets, as well as the respective genes’ names, Genbank accession
numbers, and function categories provided by the Atlas™ Glass Rat 1.0
microarray user manual. The fluorescence intensities and standard deviations
of each gene were denoted as F650 mean , F650 SD for “AEC I”, and F535
mean , F535 SD , for “AEC II”. The pixels of each spot were marked as F
pixels . The background information was similarly marked, except that  was
used instead of .
Weak spots were filtered if the mean fluorescence intensity of each spot

















meanBmeanFt , was adapted from the standard t-test
with a degree of freedom equal to 2"""" −+ pixelsBpixelsF , p  0.01. Any spots
with p>0.01 in both channels were filtered. Raw gene expression ratios of












ratiorawratio = . The normalization coefficient  was the
median of the raw ratios of the genes after filtering. This normalization is based
on the common assumption that normalized ratios would have a median of 1,
which means most of the genes do not show changes of expression levels.
The genes that consistently increased or decreased by 2-fold in both
hybridizations were identified as differentially expressed genes.
1.3.5 Quantitative real-time PCR
Data validation of DNA microarray hybridization was performed by
real-time quantitative PCR using QuantiTect™ SYBR® Green PCR kit
following the manufacturer’s instruction. Primers (Table 1,) were designed with
either Primer 3
(http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi) or Primer
Express 1.5 (Applied Biosystems, Foster City, CA). PCR Amplification was
performed on ABI PRISM 7700 (Applied Biosystems, Foster City, CA). PCR
products were purified with GENECLEAN Turbo for constructing standard
curves (10~109 copies). A standard curve was plotted with the threshold cycle
(CT) versus the logarithmic value of the gene copy number. For most of the
assays, gene copy number of unknown samples was generated directly from
the standard curve by the software Sequence Detector 1.7. In some
circumstances, logarithmic gene copy number was calculated with the best
standard curve with formula (observed CT – Y intercept)/slope. At least 2
duplications were run for each standard or unknown sample of three or more
cell preparations. All gene copy numbers were normalized to 18S rRNA.
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Table 1.1 Sequences of primer sets and thermal conditions used for real-time
PCR. GABRP: gamma-aminobutyric acid receptor pi subunit, FRAG1: fibroblast
growth factor receptor-activating protein 1, AQP5: aquaporin 5, P2X7: Purinergic
receptor P2X 7, IFN-IP: Interferon-induced protein, BAX: Bcl2-associated protein.
The Tm of the primers was set from 58oC to 60oC. Primers with similar GC content (≤
60%) were chosen. All the amplicons were ∼ 100 bp. The Tm of amplicons was
obtained from the dissociation analysis.

























1.3.6 Immunocytochemistry and immunohistochemistry
AEC II fixed with 4% paraformaldehyde were stained with anti-GABRP
with polyclonal goat anti-GABRP or anti-P2X7 antibodies (1:100 dilution),
followed by incubation with FITC-conjugated anti-goat IgG (1:2000 dilution).
Rat lung tissue sections were double-labeled with polyclonal goat anti-GABRP
or anti-P2X7 and monoclonal anti-LB180 antibodies or anti-T1α (1:1000
dilution), followed by FITC-conjugated anti-goat IgG and Cy3-conjugated
anti-mouse IgG (1:2500 dilution) as previously described [15]. The slides were
examined using a Nikon Eclipse E600 fluorescence microscope.
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1.3.7 In situ hybridization
Digoxygenin (DIG)-labeled sense and antisense probes were
synthesized from PCR-amplified cDNA (371 bp) using T7 and SP6 RNA
polymerase, respectively [16]. The primer sequences for cDNA amplification
were 5’-TAATACGACTCACTATAGGGTCACGGTGGGAAACAGG-3’ (forward)
and 5’- ATTAGGTGACACTATAGAAGGAAGGTGGAAGGGACG-3’ (reverse).
The procedure used for in situ hybridization was adapted from the protocol [17].
The slide was examined with Nikon Eclipse 600 microscope (Nikon Corp.,
Tokyo. Japan).
1.4  Results
 DNA microarray hybridizations were performed using Atlas Glass™
Rat 1.0 microarray containing 1090 genes to screen differentially expressed
genes between “AEC II” and “AEC I” for the purpose of identifying cell markers.
As the first step of data analysis, we filtered the spots where fluorescent
intensities were not significantly higher than the background via one-tailed
t-test (p 0.01) using the raw data imported from GenePix Pro. As a result, 492
genes were filtered from two independent hybridizations, and 596 genes
remained in both hybridizations. The positive controls, cDNA synthesis and
coupling reaction controls, and hybridization control, showed high ratios of
signal to background (>5) in both hybridizations, indicating the success of the
respective reactions during the RNA labeling and hybridization. Based on a
2-fold ratio change threshold, we found that 18 genes were differentially
expressed in AEC I and 42 genes in AEC II. Because only two hybridizations
were carried out for screening purpose, we chose to not present the full set of
microarray data at the present time.
9
 To validate the differentially expressed genes with quantitative real-time
RT-PCR, we first tested the precision and reproducibility of the protocol. All the
selected genes were amplified with amplification efficiencies of >90%. The CT
at 108 copies ranged from 13 to 16 cycles. All the standard curves were linear
in the range from 10 to 108 copies with correlation coefficients of >0.99. The
intra-plate coefficient of variation (CV) was less than 2%. These data indicated
that the quantitative real-time PCR was precise. The reproducibility was
demonstrated by the inter-plate CV, which ranged in 1~6%, depending on
genes and primers. The sensitivity of the protocol was about 10 copies.
However, low copy numbers normally have higher deviations. We then verified
6 genes with a high-fold change from the microarray data, 5 for AEC I:
fibroblast growth factor receptor-activating protein 1 (FGFR1), aquaporin 5
(AQP-5), purinergic receptor P2X 7 (P2X7), interferon inducible protein
(IFN-IP), and Bcl2-associated X protein (BAX); 1 for AEC II:
gamma-aminobutyric acid receptor (GABRP) (Fig. 1.1).



























Fig. 1.1 Comparison of gene expression fold changes by DNA microarray and
real time PCR. (A) “AEC I”-prominent. The fold changes are shown as “AEC I”/”AEC II”. (B)
“AEC II”-prominent. The fold changes are shown as “AEC II”/”AEC I”. Data are expressed as
mean ± SE or range. Microarray data represent two independent cell preparations for each





























 Based on the availability of antibodies, we chose GABRP and P2X7 for
verification at the protein level in cultured cells and lung tissue. Isolated AEC II
cells were cultured on plastic dishes for 1 and 7 days, and immunostained with
anti-GABRP or anti-P2X7 antibodies. As shown in Fig. 1.2, GABRP antibodies
stained day 1 cultured cells, but not day 7 cultured cells, whereas P2X7
antibodies recognized day 7 cultured cells, but not day 1 cultured cells. The
control cells in which primary antibodies were omitted did not generate signals
(data not shown).
Fig. 1.2  Immunostaining of cultured type II cells for GABRP and P2X7. Isolated AEC II
were cultured on plastics dishes for 1 day and 7 days. The 7-day cultured cells were
trypsinized and cytospun to a slide. After fixed with 4% pararformaldehyde, the cells were
stained with anti-GABRP or anti-P2X7 antibodies, followed by FITC-conjugated anti-goat IgG.
Scale bar: 10 µm.
  When rat lung tissue was double-labeled with anti-GABRP and anti-LB180
antibodies (a lamellar body limited membrane protein as AEC II marker),
co-localization of GABRP and LB-180 was observed, indicating that GABRP
was specifically expressed in AEC II, but not in AEC I (Fig. 1.3). However,
GABRP also stained the bronchial epithelial cells (data not shown). Similarly,
P2X7 was co-localized with the known AEC I marker, T1α (Fig. 1.3). The
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control slides in which primary antibodies were omitted did not show
fluorescence (data not shown).
Fig. 1.3 Dual-labeling of rat lung tissue for GABRP and LB-180 or P2X7 and T1α. Rat
lung tissue was fixed with 4% formaldehyde and incubated with anti-GABRP and anti-LB180
antibodies or anti-P2X7 and T1α, followed by FITC-conjugated anti-goat IgG and
Cy3-conjugated anti-mouse IgG. Two different magnifications (x 40 and x100) are shown.
Scale bar: 20 µm.
Fig. 1.4  In situ hybridization of GABRP in rat lung tissue. Rat lung tissue was
formaldehyde-fixed and paraffin-embedded. The slide was hybridized with DIG-labeled
antisense (A) or sense (B) probe and detected by DIG Detection kit. Arrows point to staining of
type II cells.
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To confirm that GABRP mRNA is expressed in type II cells in vivo, we
performed in situ hybridization using rat lung tissue. A GABRP fragment (371
bp) containing T7 (sense strand) or SP6 (anti-sense strand) RNA polymerase
promoter was generated by PCR. Digoxigenin (DIG) labeled anti-sense- and
sense cRNA probes were produced in vitro using SP6 or T7 RNA polymerase.
As shown in Fig. 1.4, the anti-sense GABRP probe binds to the cells located in
the corner, suggesting its location of type II cells. The sense probe did not
generate signals.
1.5  Discussion
The regeneration of squamous alveolar epithelium following lung injury
occurs by proliferation of AEC II with subsequent trans-differentiation into AEC
I. Isolated AEC II, when cultured on plastic dishes for several days acquires
AEC I-like phenotypic characteristics. Utilizing this unique property of AEC II,
the present study was designed to identify the genes that can be used as
markers for AEC I and AEC II by DNA microarray containing 1090 rat genes,
real time PCR, immunohistochemistry and in situ hybridization.
We have verified one AEC II gene (GABAP) and five AEC I genes
(FRAG1, AQP5, P2XP7, IFN-IP and BAX) using real time PCR. GABRP, a pi
subunit of the GABA “A” receptor family, was specifically expressed in AEC II
but not in AEC I cells as revealed by DNA microarray, real time PCR and
immunostaining and in situ hybridization on rat lung tissue. Although it exists in
brain, uterus, and some extent in lung, this is the first report to demonstrate its
localization in AEC II. The expression of GABRP has been directly correlated
with uterine contractility [18]. GABRP is expressed throughout pregnancy and
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decreases considerably during labor. Transfection of GABRP in HEK-293 did
not express binding sites for the GABA receptor ligand (35S TBPS) and failed
to elicit chloride currents in response to GABA or glycine. However,
transfection along with GABA receptor beta 3 showed the change in the
sensitivity of the receptors to pregnanolone, suggesting that the
GABRP-GABA receptor beta 3 complex form a active channel [19]. The
function of GABRP in AEC II is not known. Because GABA receptors are Cl-
channels, GABRP may regulate fluid transport in lungs.
Among the genes expressed in AEC I, AQP-5 is a known marker of
AEC I and functions as a water channel. AQP-5 is expressed in adult rat lung
and participates in fluid clearance [20]. AQP-5 -/- mice showed a higher
hyper-responsive level than did AQP-5 +/+ mice to intravenously administered
acetylcholine, indicating that AQP-5 influences bronchoconstriction [21].
FRAG1, discovered as a cancer-promoting gene, may activate fibroblast
growth factor receptor by C-terminal fusion through chromosomal
rearrangement and stimulate the transforming activity and
autophosphorylation of FGF [22;23].
Purinergic receptors are composed of P2Y and P2X, and are activated
by extracellular nucleotides. Binding of ATP to P2Y receptor activates the
G-protein coupled to phospholipase C, raises inositol-1,4,5-triphosphate and
intracellular Ca2+, and, thus, increases surfactant secretion in AEC II [24]. P2X
receptors are ATP-gated ion channels. Isoforms of P2X receptors were found
in respiratory epithelium [25;26]. P2X4 has been detected in AEC I [27]. The
activation of P2X stimulates secretory Cl- transport across epithelia. Recent
studies have indicated that AEC I express Na+ channels and AEC I may
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contribute to fluid transport in the lung [6;7]. The present finding that P2X7 was
expressed higher in AEC I suggested that P2X7 may regulate Cl- transport.
Interferons induce gene expressions of various proteins including
antiviral proteins, chemokines, heat shock proteins, etc. [28]. IFN-IP has 70%
similarity to the human alpha-IFN-induced gene, 9-27 [29]. The latter is a cell
surface protein, leu-13 and mediates antiproliferation and cell adhesion [30].
The function of IFN-IP in AEC I is yet to be determined.
BAX is a pro-apoptotic regulatory protein. Activation of BAX leads to its
relocation from cytosol to mitochondria, causes the release of cytochrome c,
and promotes apoptosis [31]. A higher expression of BAX in AEC I than AEC II
indicates that AEC I may undergo active apoptosis.
In summary, the present study identified several genes specifically
expressed in AEC II or AEC I. Some of those genes could be used as potential
markers for these cell types.
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RealSpot: Software Validating Results from
DNA Microarray Data Analysis with Spot Images3,4
2.1  ABSTRACT
The spot images from DNA microarray highly affect the discovery of
biological knowledge from gene expression data. However, results from quality
analysis, normalization, differential expression, and cluster analysis are rarely
validated with spot images in current data analysis methods or software
packages. We designed RealSpot, a software package, to validate the results
by directly associating spot quality and data with spot images in a spreadsheet
table. RealSpot splits hybridization images into individual spots stored in a
spreadsheet table. It subsequently associates microarray data with spot
images and performs data validation through the standard table operation such
as sorting, searching, and editing. RealSpot has several built-in functions to
facilitate data validation, including spot quality analysis, data organization,
one-way ANOVA, gene ontology association, verification, import, and export.
We used RealSpot to evaluate 77 slides (30,000 features each) from real
hybridization experiments, and to validate results from each step of data
3 Reprinted from Physiol Genomics, 21, Zhongming Chen and Lin Liu, RealSpot: Software
Validating Results from DNA Microarray Data Analysis with Spot Images, 284-91, Copyright
(2005), with permission from American Physiological Society.
4 Contributions of co-authors: Liu L is the principal investigator.
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analysis. It took about 10 min to validate results of spot quality after initial
evaluation and correct ~ 0.3% of falsely assigned qualities of 10K spots. We
validated 1,641 of 2,110 differentially expressed genes identified by SAM
analysis in about half an hour by comparing each gene with its respective spot
image. Furthermore, we found 6 of 48 genes in one cluster from k-mean
clustering method showed inconsistent trends of spot images. RealSpot is
efficient for validating microarray results and thus helpful for improving the
reliability of the whole microarray experiment for experimentalists.
2.2  Introduction
 DNA microarray is a high throughput technique for the investigation of
mRNA abundance (5). Gene probes on one slide are hybridized
simultaneously with cDNA or cRNA samples labeled with fluorescence dyes,
yielding images containing thousands of spots. The mRNA abundance is
obtained by extracting quantification information from all spots on the images
(“raw data”). According to the minimum information about microarray
experiment (MIAME) guidelines, a microarray experiment is organized as gene
probes, print layout, samples, hybridization images, raw data, and data
normalization (2).
Raw data from the hybridization images are the fundamental information
for further data analysis including data normalization (8), statistical inference
(10), cluster analysis (4), principal component analysis (PCA) (9), pathway
construction (3; 11) and data interpretation. The results of a microarray
experiment depend on the quality of hybridization images and the respective
raw data sets. However, results from each analysis step are rarely validated
with spot images in current data analysis methods or software packages. A
22
typical data analysis procedure of microarray is as following: extracting
quantification data from images, filtering data with chosen standards (e.g.
background-to-noise ratio >2), normalizing log2 ratios, identifying differentially
expressed genes (e.g. 2-fold change of expression or statistical inference with
p=5), clustering genes (e.g. hierarchic or k-mean clustering), and selecting
target genes for further study. Microarray data analyses confront with
challenges of diverse methods, standards and software packages. An example
is spot quality evaluation discussed below.
The image quality varies from spot to spot due to printing, sample quality
and hybridization. Ideally, all the spots with a poor quality should be filtered
before further data analysis. There are two main approaches for filtering poor
quality spots: manually flagging spots and automatically filtering genes (1; 6;
12; 13). Manually flagging spots is time-consuming due to the large number of
spots in a microarray slide. Automatic methods based on quantification
information are fast and efficient. These methods calculate composite scores
from spot size, intensity, signal to background ratio (SBR), and/or circularity
coefficient (area-to-perimeter ratio). Generally, the composite scores represent
several aspects of spot images. These methods may fail at spots with irregular
morphology, e.g., donuts, black holes (“ghost images”), and tiny-dust
contained spots. Although they are suitable for large scale data analysis,
different methods or parameters frequently generate non-trivial different results
from an identical raw data set. In such a case, to validate results and choose
an appropriate method is not straightforward. The association of spot images
with derived data may identify irregular spots. Some of software packages
such as Acuity and Longhorn/Standford Microarray Database (LMD/SMD) can
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locate each spot image on a single slide (7). Acuity locates a spot image on a
scanned slide image using GenePix results, while LMD can show a spot image
as well as other retrieved data in a data query report. In both cases, only a
single spot image can be retrieved to validate the derived data from one slide.
Here, we report a software package, RealSpot, for validating results from
dual-color DNA microarray hybridizations. RealSpot evaluates spot quality and
validates it with spot images. RealSpot links the images and raw data of each
spot side-by-side and organizes them in a spreadsheet table. By standard
table operation such as sorting, searching, and editing, a user can directly
compare the spot images, raw data, and processed data in an efficient and
reliable way. Furthermore, RealSpot provides tools for one-way ANOVA, gene
ontology, and web page export, which are also helpful in choosing target genes
for further study and thus improving the reliability of the whole microarray
experiment. It is freely available for academic use, and can be obtained at
http://www.cvm.okstate.edu/research/Facilities/LungBiologyLab/RealSpot.htm
or via e-mail request (liulin@okstate.edu).
2.3  Implementation
2.3.1 General workflow
 The basic workflow of RealSpot is composed of 5 modules: data import,
quality evaluation, data organization, data verification, and data export (Fig.
2.1).  The data import module converts raw data, images, and sample
information into a spreadsheet table. The quality evaluation module evaluates
data quality using spot images and raw data from each slide and stored as a
binary slide file. The data organization module organizes slide files as an
experiment, visualizes data in a meta-table based on the sample information,
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performs one-way ANOVA, and associates gene ontology information
(http://www.geneontology.org) with gene list in a microarray experiment. The
data verification module validates the results by searching a group of genes
obtained from down-stream data analysis, e.g. K-mean cluster, and then
comparing them with raw data and spot images. The data export module
exports spot images, quality index, and normalized data as images, web pages,
and text files for data presentation, internet data communication, and further
analysis. Each component is implemented as a module to guide a user in
finishing the respective operations step by step. The following is the detailed
description of these components.
2.3.2 Data import
An import module imports raw data and image files, and collects sample
information of the respective slide. The raw data files such as GenePix result
(GPR) file are tab-delimited flat text files containing gene ID, gene name,
geometry of subarray grids (block or meta-row and meta-column), and spots in
each subarray (row and column). The GPR file also holds spot geometry (x, y,
and diameter) for image splitting, and gene expression data (fluorescence
intensity, background, and ratio). The image files are 16-bit TIFF (Tag Image
Format File, 16-bit image pixel: 0~65,531) files directly generated by a scanner,
e.g. ScanArray™ Express. During data import, each 16-bit TIFF image is split
into spot images using the spot geometry x, y, and diameter from the
respective raw data file. The spot images are then linearly transformed into
8-bit for visualization. The linear transformation is based on the whole image or
individual sub-grid. By default, the lowest 5 percent image data are converted









= , where f8 is the intensity of a transformed 8-bit image pixel
(0~255 for image visualization), F16 is the original 16-bit fluorescence intensity
of each pixel, and P5 and P95 are the 16-bit intensities at the 5th and 95th
percentiles from a slide image or a sub-grid, respectively.
Fig. 2.1 Overview of RealSpot. There are
five components shown as gray boxes in
RealSpot. Import module imports raw data
file and TIFF image files into RealSpot.
Quality module evaluates spot images and
data, and saves them as a slide file. Data
sort function facilitates the quality evaluation.
Oraganizer module organizes multiple slides
in a Meta-table. Verification module confirms
the final results with spot images and raw
data by searching selected genes. Export
module exports spot images or data quality
and gene expression data of selected genes.
Data Normalizer normalizes raw data and
draws a scatter plot. The solid text boxes are
the functional modules in RealSpot, the
rectangle and ovary white text boxes are
sample and data information, and the files
used by RealSpot, respectively. The arrows indicate the workflows of data or module calling.
During data import, a user is also asked to import sample information
including the sample names and the respective dye channels (green or red). In
a RealSpot spreadsheet, each row represents a gene and each column
contains gene probes (gene ID and name), information of array print layout
26
such as block, and sub-array, spot images, and raw data such as fluorescence
intensity and background (Fig. 2.2). Additional columns are added to the table,
e.g., quality index, 16-bit spot signal, and SBR calculated directly from 16-bit
TIFF images (see below).
Table 2.1 Quality index and icon
Icon Meaning Default threshold* Quality Index
Empty spot <30% 0
 Weak and ambiguous spot 1
 Middle and clear spot** 2
Strong spot 3
Saturated spot >=95% 4
 Contaminated spot SBR<2 5
* Signal percentiles of 30% and 95% were obtained from a plot of intensity-gene rank
percentage. SBR: Signal-to-background ratio. See the text for details.
** Compared with weak and ambiguous spot, the spot is stronger and its shape is clear
from background.
2.3.3 Quality evaluation
The main purpose of RealSpot is the quality evaluation of spot images and
raw data, and the verification of the final data analysis results with the spot
images. RealSpot first evaluates spot quality based on the signal intensity and
SBR, and assigns a quality index (QI) to each spot. QI 0-4 indicate empty,
weak, middle, strong and saturated spots, respectively (Table 2.1). By default,
QI 0 and 4 are assigned to the empty and saturated spots, whose intensities
are less than 30% and greater than 95%, respectively. QI 1-3 is calculated,








QIij is the quality index of spot j on slide i and Iij the intensity of the spot j on
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slide i. By default, I0 is the intensity at 30th percentile, and I1 at 95th percentile of
the plot (intensity vs. gene rank percentage) of the slide image. These settings
may be adjusted based on visual estimation (Fig. 2.3). A QI of 5 is assigned to
a contaminated or bad spot based on SBR. By default, any spots with a SBR of
<2.0 are given a QI of 5. QI is visualized as an icon (Table 2.1). The QI 0~4 are
shown as columns, the shorter height the weaker intensity. A QI of 5 is shown
as a prohibiting cross.
Fig. 2.2 Data visualized in a Meta-table. Tables from four slides are grouped as a meta-table,
in which spot image cells contain sub-rows and sub-columns. Each row represents the
information of a gene. The columns from left to right are gene ontology, gene ID, gene name,
signal summary, quality index (QI) summary, spot images of each sample from each slide, and
data column (P-value) for sorting the table. The yellow frames on spot images highlight current
sample (brain) and table (slide 3). The error bars of signal summary and QI summary are
standard deviations. Significantly differentially expressed genes are highlighted with thick lines
(p-value <0.05).
A small portion of spots (<0.3%, typically 10 out of 30000 features) may be
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falsely assigned a QI by the initial evaluation based on signal intensity and
SBR, and thus a manual correction is required (see Results section). RealSpot
facilitates the manual correction in three ways. First, as an option, a user may
choose an additional data column from upstream software, e.g. “flags” column
from GPR files. If such a column is provided, RealSpot compares QI with this
column. If a spot is marked as “bad” (SBR<2.0) by RealSpot but as “good” by
GenePix (flag= -100), RealSpot ignores SBR criteria and reassign a quality
index. Second, some good spots with a very large diameter may be found to
have a QI of 5. Such “bad” spots frequently have a much larger diameter than
an average spot of a whole slide. RealSpot marks these spots with a
question marker “?” to prompt a user to manually check and correct. These
spots are assigned a temporary QI (=21) to distinguish them from other spots.
This QI is either replaced by a user-corrected QI or restored to 5 after re-open
the file if a user ignores these spots. Third, RealSpot offers tools to facilitate
the manual correction by sorting similar quality spots together using QI, spot
diameter, signal intensity, or spot image, and correcting them at once. Some
irregular and contaminated spots may be assigned a QI of 1-4. A user may
select these spots, and assign a right QI to them using an annotation tool.
RealSpot also offers another tool to identify the spots with a similar shape by
comparing the images of a selected spot (e.g., a contaminated spot) and all
other spots in this channel, and calculating an image similarity (IS) for each
spot based on Pearson’s correlation coefficient:












Where, ISf is the image similarity of a spot image F, which has n pixels
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marked as Fi (i=1~n), to the selected spot C, marked as Ci (i=1~n). The
summations are based on index i and calculated from i=1 to n. IS value is
ranged from 1 (identical spots) to 0 (entirely different spots). RealSpot then
sorts the spots by IS, so that spots with similar images are arranged together.
After sorting, the selected spot moves to the first row of the top, followed by
other similar spots. A user may manually check these similar spots and correct
QI accordingly, since these spots has similar morphology.
Fig. 2.3 A plot for defining quality index. The chart
was plotted as signal fluorescence intensity vs gene
rank percentage (1~99%). By default, quality index (QI)
of 0 and 4 was assigned to the genes whose
intensities were <30% and >95%, respectively. These
percentages can be adjusted based on the
pseudo-color spots in the top grid. QI 1 - 3 are
calculated as described in the text. A QI of 5 for bad
spots was determined by signal-to-background ratio
(<2 by default). The check box, “flags” from upstream
image quantification (e.g. GPR file from GenePix) is an optional column for QI evaluation.
2.3.4 Data organization
When there are more than one hybridizations or slides in one DNA
microarray experiment, RealSpot organizes the evaluated slides as an
experiment for calculating quality index summary, spot signal summary,
performing one-way ANOVA, associating gene ontology information with each
gene, and retrieving data to verify results. RealSpot uses sample information
of each slide and aligns slides by sample names. A user can import multiple
slide files into a meta-table at the same time by selecting the file names. A
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column for summarizing quality index of each spot from multiple slides is
added into the meta-table. This column is calculated as following: the
contaminated or bad spots are first removed; the mean and SD of the QIs are
calculated from spots with a QI of 0, 1, 2, 3 and 4; the mean QI is round to an
integer and shown as an icon as shown in Table 2.1 and the SD is shown as an
error bar (Fig. 2.2). A column of spot signal summary from multiple slides is
calculated as following. The 16-bit signal intensities of each channel are scaled
to an arbitrary range (1~1,000 in RealSpot). The data scaling serves as a
global normalization, so that the gene expression data from different slides are
comparable. The data scaling is based on an assumption that the lowest 5%
genes are not expressed (i.e., negative spots) and converted to 1, and the
highest 95% spots are highly expressed (i.e., saturated spots, typically from
housekeeping genes) and converted to 1,000. The rest spot signals are
linearly scaled to 1~1,000. The mean and SD of scaled spot signals for each
sample group are calculated, and visualized in the column as bar plots. A
one-way ANOVA is performed based on the above globally normalized signals,
if 3 or more slides are used in an experiment. Prior to ANOVA, normalized
signals are logarithm transformed, which can improve the homogeneity of
standard deviations among sample groups (a pre-requirement of ANOVA). A
p-value of each gene is obtained from ANOVA. RealSpot highlights the bar
plots of significant genes (p-value< significance level, default=0.05) with thick
lines. This indicates that there is a significant difference of gene expression for
at lease two samples. RealSpot also accepts gene ontology association files
(tab-delimited ext files with columns of GO ID, gene symbol, gene ID, GO term
and GO part). If a gene ontology file is read, a column of ontology is added to
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display the functions of known genes (Fig. 2.2). In the meta-table, some
columns are the same for all the slides such as gene ID and name, printing
layout information, and summary quality index. Other columns such as quality
index and spot images are specific for each slide and are organized as a
sub-table within the respective row of each gene. A sorting column is used for
showing information for sorting, e.g. “P-value” column in Fig. 2.2.
2.3.5 Data verification
The data verification module directly compares DNA microarray data with
spot images, providing an additional step for quality control, and more
importantly, a method to validate data analysis results. After data quality
evaluation, the filtered data set can be used for further data analysis such as
cluster analysis or hunting differentially expressed genes. From the
down-stream analysis, a researcher may obtain a list of genes and associated
data, such as the genes with similar normalized ratios, differential expression,
expressed pattern across a serial of conditions. Before further analysis or
functional studies, a user may compare the final genes with the respective spot
images by clicking “search genelist” button in Fig. 2.2 to search and group
these genes, and optionally, the associated data. RealSpot shows all the found
genes on the top of the meta-table. It is relatively easy for a human being to
identify a few distinct spots from other spots showing a similar pattern.
Consequently, search by genelist in RealSpot is efficient for identifying the
inconsistence of data analysis results and spot images. The inconsistent
genes may be eliminated from further analysis, or an alternative method may
be chosen to analysis the same data set and consistent results achieved.
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2.3.6 Data export
Spot images, raw data as well as quality index can be exported by
selecting interested genes or items. An ExportModule guides a user exporting
the respective information. For image export, the spot images of selected
genes are exported as a Windows Enhanced Metafile (EMF), bitmap file
(BMP), and web pages (hypertext markup language files, HTML). The EMF file
is the default format. It contains the instructions for drawing the text and spot
images, and has a very high resolution. It is best for printing high quality image.
The file formats can be read by most image and word processing software
packages. RealSpot also exports the summary quality index and gene
expression ratio of two samples. RealSpot can export hundreds or thousands
of genes as a HTML file. A user may directly post it on internet for data
communication among internal lab members or external DNA microarray
communities. Before data export, RealSpot provides tools for data
normalization and scatter plotting.  A user may select two samples and filter
spots by quality index or directly select spots from the Meta-table. The scatter
plot visualizes the global distribution of the signal intensity of the selected
genes in two samples. Global or intensity-dependent normalization methods
are provided. LOWESS normalization (15) based on print tip is the default. A
user may select an appropriate normalization method based on the scatter plot.
RealSpot exports the gene ID and name, quality index and normalized
expression ratio of select genes and samples as a tab-delimited text file.
2.4  Results
2.4.1 Environment requirement
RealSpot is an executable under Windows 98 or above operation system. The
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minimal hardware configuration is 250 MHz Pentium III CPU, 64 MB memory
and 200 MB free hard disk space for storing data. For experiments with
multiple slides, a current main stream computer with 2.6 GHz Pentium IV CPU,
512MB memory and 2GB free hard disk space is recommended. The following
performance results are based on the recommended computer.
2.4.2 Performance
It took about 10s for RealSpot to import raw data and two images of a slide
with 30,000 features. The table file created by RealSpot was around 20 MB or
1/3 of the total size of the imported raw data and image files (60 – 70 MB).
RealSpot evaluates one slide based on the intensity and SBR in about 500 ms.
It takes about 5 - 10 min for a user to semi-automatically correct spot quality
index. Current version RealSpot can manage an experiment with hundreds of
slides. For loading 77 slide files (30,000 spots each) from a whole experiment,
RealSpot only spent about 10 s because of the compact size and binary format
of table files. The slowest performance of RealSpot was data exporting, due to
the intensity-dependent LOWESS normalization. RealSpot spent about 10 s to
normalize a table, or 3 min for a whole experiment of 20 slides.
2.4.3 Quality evaluation
During the above performance test, about 0.3% of the spots (100 of 30K)
of each slide were semi-automatically corrected after initial quality evaluation
based on visual and subjective observation of spot images. By sorting, these
spots were grouped at the end of the table. Most of these spots were extremely
big and were falsely identified as bad spots. It took 5-10 min to correct these
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spots for each slide. This is a substantial time saving, compared with GenePix,
by which we normally spent several hours on manually evaluating the location
and quality of individual spots through a whole slide.
To assess the data quality after the quality evaluation, we compared the
scatter plots after data filtering using different ranges of QIs. As shown in Fig.
2.4, most of bad spots and empty spots were in the lower intensity end. After
filtering these spots (QI=0 or 5), more consistent results were obtained.
Table 2.2  False-counts of negative and positive probes from RealSpot and GenePix
Control GenePix RealSpot
False-positive 23.5±35.0 19.5±10.9Negative
(169) True-negative 145.5±37.7 146.3±84.6
False-negative 12.2±17.4 0.4±1.9Positive
(86) True-positive 73.9±19.3 85.5±4.0
Results were based on 169 negative control probes and 86 highly abundant genes (e.g.
ribosomal proteins and GAPDH) in a 10 K rat DNA microarray. There were 24 replicated
spots for each gene probe. Spot counts were average ± standard deviation. False-positive
counts in negative control probes were based on a flag of 0 in GenePix and a QI of  1 in
RealSpot. False-negative counts in positive control probes were based on a flag of <0 in
GenePix and a QI of 0 or 5 in RealSpot.
Furthermore, we compared RealSpot with GenePix for quality evaluation
by counting false-positive spots from negative control probes or false-negative
spots from positive control probes (Table 2.2). There are 169 Arabidopsis
probes used as negative controls in our 10K rat DNA microarray. The false-
positive spots identified by RealSpot from these negative control probes (a QI
of 1) were slightly lower than those by GenePix (a flag of  0). It is noteworthy
that the false-positive spots from RealSpot had a QI of 1, which means weak
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or ambiguous spots. A user may filter such weak spots in a particular
experiment, and these spots might not be false-positive in such a circumstance.
For positive control probes, we choose 86 highly abundant genes such as
ribosomal proteins and GAPDH. There was a significantly lower false-negative
spot counts in RealSpot than these in GenePix (p<5).
Fig. 2.4 Scatter plots after data filtering based on quality index.  X and Y-axis are
background subtracted signal intensity from a lung-lung self-hybridization image after quality
evaluation. Data were plotted to show spots within various QI ranges.
2.4.4 Result Validation
Using RealSpot, we also compared spot images with the results from
different stages of data analysis, such as data filtering, data normalization,
differential gene expression and cluster analysis (Fig. 2.5). The spots shown in
Fig. 2.5A had an identical flag of -100 for both red and green channels,
generated by GenePix. These spots were identified as bad spots by GenePix.
However, some of spots obviously are good spots as evaluated by spot images
and QIs generated by RealSpot (Fig. 2.5A). We used two methods to
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normalize data: log2 transformed ratios from background-subtracted signals
(e.g., “F535 mean – B535” data column in GenePix raw data) were normalized
by LOWESS based on print-tip (Fig. 2.5B), or by globally adjusting log2 ratio
median to 0 (Fig. 2.5C). The genes shown had a 2-fold increase of expression
(heart vs lung). Compared with spot images, it appears that the log ratios from
global normalization was more consistent with spot images than these from
LOWESS normalization in this particular example. Based on the normalized
log2 ratios, we identified a set of differentially expressed genes by SAM (Fig.
2.5D) or ANOVA (Fig. 2.5E). The genes shown in Fig. 2.5D or 2.5E should be
expressed significantly higher in lung than in heart, and were generally
consistent with spot images. However, the first gene in Fig. 2.5 D or Fig. 2.5E
might be considered to be eliminated from further studies, since there were
two strong replicated spots in heart column (2) for the former and the gene
expression level appeared to be very weak for the latter. We validated 1,641
out of 2,110 differentially expressed genes identified by SAM test in about half
an hour in this way. About 22% differential genes were eliminated because of
inconsistence between log ratio and spot images or very low gene expression
levels (weak spots). Using K-mean cluster analysis (4), we identified 10
clusters from 6 tissue hybridizations (lung, heart, kidney, liver, spleen, and
brain). One of the clusters is spleen-specific genes (Fig. 2.5E and 2.5F) The
spot images were generally consistent with expression patterns from cluster
analysis, except the second gene, which apparently was a false-positive result
and should be eliminated from further study. We found 6 out of 48 genes in a
whole cluster showed inconsistent trends between gene expression levels
(normalized signal in arbitrary unit) and the respective spot images.
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Fig. 2.5 Validation of the results at different stages of microarray data analysis.  (A)
Spots with a spot flag of -100 (bad spot) generated by GenePix from lung (column 1) – lung
(column 2) self-hybridization. The two icons in each row of column Q were the QI of column “1”
and “2” from RealSpot, respectively. (B, C) All of the spots have a normalized log2 ratio of 1.0
(lung/heart, column 1/2) by LOWESS (B) or global (C) normalization. (D, E) The genes with 4
replicated spots were differentially expressed in lung (column 1) vs heart (column 2) identified
by SAM (q-value=0.05) (D) or ANOVA (p-value=0.05) (E). Column S indicates QI summary of
the respective spots. (F, G) One cluster genes identified by k-mean cluster analysis (k=10)
from tissue hybridizations: lung (1), heart (2), kidney (3), liver (4), spleen (5) and brain (6).
Column S in Panel F represents QI summary. The signals in the y-axis of Panel G were
relative gene expression levels of genes among the six organs in arbitrary unit (AU).
2.5  Discussion
We designed a software package, RealSpot to validate the results from
DNA microarray experiments at any stages of data analysis by directly
associating spot quality and results with spot images. RealSpot evaluates
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DNA microarray data quality by assigning a quality index to each spot based
on signal intensity and SBR, followed by directly comparing spot images, raw
data, and analysis results. The reliability of quality evaluation is dependent on
both spot images and the respective raw data. The direct comparison of spot
images and raw data makes the quality evaluation more reliable than using
either of them separately. RealSpot also has several built-in functions including
search, sort, data organization, one-way ANOVA, gene ontology, data
normalization, plotting and web page generation. Furthermore, step-by-step
Modules make RealSpot easy to use.
 The spot images are directly imported from scanned microarray slides and
linearly transformed to 0-255, representing original image information. This
linear transformation trims the extreme signals, i.e., the lowest and the highest
5% of image signals, since the former usually is background noise, and the
latter the saturated signal. Trimming these signals does not lose much image
information, but makes 90% pixels visible without adjusting brightness and
contrast. This method is similar to Affymetrix data normalization, which linearly
transforms fluorescence intensity to an arbitrary range, e.g. 0 ~ 10,000. The
advantage is that different slides are comparable after transformation. We
noticed that some slides show differences among printing tips. We therefore
added an option in RealSpot for a separate transformation of each sub-array
or block from an identical printing tip to compensate such differences, similar
to the printing tip-based LOWESS normalization (8). We generated
quantitative data (signal intensity and signal-to-background ratio) by RealSpot
from original 16-bit spot images located by geometric data from GenePix (x, y,
and diameter) for quality evaluation and verification of the original raw data
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from image analysis software packages. Signal intensity and SBR were
affected by spot alignment algorithms but not spot segmentation algorithms
(14). In RealSpot, the image of each spot was split from a whole slide at the
respective spot center (x,y). The size of each spot image was identical, i.e., the
average distance between two adjacent spots. The signal intensity was the
average intensity of the whole transformed image of a spot, and the SBR was
estimated from the center ¼ area (for signal) and the four corners (for
background). The problem in term of assigning a quality index to large spots
was associated with the estimation of SBR in RealSpot. The problematic spots
usually had a diameter larger than the average distance between two adjacent
spots. The four corners of these spot images were largely occupied by the
spots. Consequently, the estimated SBR was lower than true SBR and thus a
larger spot may be falsely assigned a QI for a contaminated spot. This problem
would be even worse in the slide area where large spots were clustered
together. A potential solution would be the estimation of SBR using global
background through a whole slide, since this problem was resulted from the
estimation of local background. Currently, we do not test global background,
since local background works well with 99.7% spots for identifying low quality
spots in our results.  However, in RealSpot, these falsely assigned QI can be
manually corrected in a quick table operation style: sorting, selecting, and
editing. Comparing the time-consuming manual spot correction in a whole
slide as does in GenePix , the quick manual correction in a table as does in
RealSpot results in a higher efficiency.
The data imported from raw data and transformed images are useful for
manual evaluation. For instance, the contaminated spots move together when
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the table from a slide is sorted by “flags”, “SNR”, or “B535 mean” column (from
GPR file). These contaminated spots may be manually selected and remarked
simultaneously. Sorting table also helps to correct errors, in particularly, weak,
noisy or irregular spots. On the other hand, some spots may be marked as bad
spots based on SBR, but they are good spots by visual assessment. Most of
the reported automatic methods were based on raw data, using some criteria
such as signal-to-noise ratio, SBR, circularity coefficient, and composite score
(1; 6; 12). We found that these criteria were sometimes inconsistent with spot
images. For instance, many weak spots have high SBRs because both their
signals and backgrounds are closed to 0. Some spots with a good morphology
and intensity may be contaminated with a few tiny dusts. These spots are good
spots if manually marked, but may be identified as bad spots because their
SNRs are low. These spots can be corrected by sorting the quality index
column, followed by spot diameter column. In RealSpot, the quality indexes of
all the spots can be corrected in 5 ~ 10 minutes for 30,000 spots, and thus the
mistakes that are unavoidable for automatic tools are minimized.
The one-way ANOVA implemented in RealSpot simplifies multiple
statistical factors (e.g. dye, slide, and sample treatment) to one factor (sample
treatment). The original 16-bit gene expression data from each slide are
globally scaled to an identical range (1~1000) and logarithm-transformed for
calculating p-values. The p-values from this simplified one-way ANOVA can be
used for fast monitoring differentially expressed genes. For instance, a gene
with a lower p-value than a significance cutoff (p-value=0.05) may be
considered as a significantly differentially expressed gene for further
investigation. The significance cutoff may be adjusted, e.g. Bonferroni
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adjustment, which sets p-value cutoff=
n
05.0 , (n=total gene number). The
adjusted cutoff may decrease type I error (false-positive).
The gene ontology information of known genes is helpful for understanding
gene functions. In a typical ontological annotation file, a gene is assigned
multiple GO IDs, reflecting the molecular function, biological process, and
cellular location. RealSpot summarizes all the ontological annotations of each
gene, and thus provides a user with comprehensive information of a gene.
Based on the p-value from one-way ANOVA and ontological annotation, a user
can quickly find interesting genes and their potential roles in a particular
experiment.
RealSpot is efficient. It evaluates and assigns a QI to each spot
immediately after data import. A user also can identify incorrectly evaluated
spots, by sorting similar spots together using spot images and raw data.
Another feature is the icons used for quality indices. RealSpot uses standard
scores 0-4 and represents them as bar plot-like icons to visualize spot quality
(Table 2.1). It is easier for a user to compare a spot with the respective icon
than with a number. It is also helpful for visualizing the trends of gene
expression level when several slides or samples are grouped together.
RealSpot is flexible and easy to use. First, the images from many DNA
micrarroay scanners, and raw data from commonly used image analysis
software packages can be directly imported. The import module guides a user
importing data step by step with detailed help information. RealSpot skips the
description of some raw data files, e.g. GenePix GPR files, and imports user
selected columns of raw data. By organizing raw data and spot images in a
table, the user interface of RealSpot is similar to Microsoft™ Excel worksheets.
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Under such operation environment, a user can focus on data evaluation
without learning new instructions for operating software. The ExportModule
exports the table as a text file for importing to database or data analysis
software. Images can be exported in bitmap or metafile formats. These formats
are most popularly supported in Windows operation systems. Organizing data
by samples and slides clearly displays microarray experimental designs such
as a loop or reference design, and helps a user to interpret data from biological
samples.
RealSpot is designed for quality evaluation of raw data and spot images,
not for data analysis, although some simple data process tools such as data
normalization are included. Further improvement of RealSpot may include
image transformation, a direct link to database, and data analysis tools. In the
current version of RealSpot, a 16-bit image is linearly transformed to an 8-bit
image for display. A square root transformation may be used to strengthen
weak spots.  A direct link of RealSpot with database will help a user manage
microarray data. More powerful sort and search tools may be implemented in
Meta-table. Another limitation of the current RealSpot version is that it can only
work with images from dual color hybridization and this issue should be
addressed in the future version. In summary, the software package, RealSpot
is efficient for validating microarray results and thus helpful for improving the
reliability of the whole microarray experiment. The improvement is resulted
from the association of micorarray data with the respective spot images.
2.6  Availability and requirements:
2.6.1 Project name: RealSpot
2.6.2 Project home page:
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http://www.cvm.okstate.edu/research/Facilities/LungBiologyLab/htm/software/index.html
2.6.3 Operating system(s): Windows 98 or above operation system.
2.6.4 Programming language: Delphi (version 6)
2.6.5 Other requirements: None
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Chapter 3
Identification of rat lung - prominent genes by a parallel DNA microarray
hybridization 5,6
3.1  ABSTRACT
Background-The comparison of organ transcriptomes is an important strategy
for understanding gene functions. In the present study, we attempted to
identify lung-prominent genes by comparing the normal transcriptomes of rat
lung, heart, kidney, liver, spleen, and brain. To increase the efficiency and
reproducibility, we first developed a novel parallel hybridization system, in
which 6 samples could be hybridized onto a single slide at the same time.
Results-We identified the genes prominently expressed in the lung (147) or
co-expressed in lung-heart (23), lung-liver (37), lung-spleen (203), and
lung-kidney (98). The known functions of the lung-prominent genes mainly fell
into 5 categories: ligand binding, signal transducer, cell communication,
development, and metabolism. Real-time PCR confirmed 13 lung-prominent
genes, including 5 genes that have not been investigated in the lung, vitamin
5 The manuscript of this chapter has been submitted to BMC Genomics. Contributions of
co-authors: Jiwang Chen and Tingting Weng took part in tissue sample collection and DNA
microarray hybridization; Nili Jin took part in real-time PCR, and Lin Liu is the principal
investigator
6 Our microarray dataset has been submitted to GEO and can be accessed by following steps:
1. Go to webpage http://www.ncbi.nlm.nih.gov/projects/geo/;
2.   Go to the bottom of this page;
3. Login to GEO; a. user: zhongmingchen; b. password:123456; c. Click  button “Login”;
4. Go to our data set; a. GEO accession: GPL1699; b. Click button “GO”;
5. View dataset by click hyperlinked items of “Sample id”)
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D-dependent calcium binding protein (Calb3), mitogen activated protein kinase
13 (Mapk13), solute carrier family 29 transporters, member 1 (Slc29a1),
corticotropin releasing hormone receptor (Crhr1), and lipocalin 2 (Lcn2).
Conclusions-The lung-prominent genes identified in this study may provide
an important clue for further investigation of pulmonary functions.
3.2 BACKGROUND
    With the completion of genome projects of human and other model
species, functional studies on a genomic scale are coming to a frontier. The
investigation of transcriptome reveals gene expression of organs and cells
from normal and diseased animals and humans. By comparing transcriptomes
of multiple organs, physiological functions in different organs can be further
explored. Identifying the genes expressed prominently in the lung may reveal
its unique physiological functions in the respiratory system.
    The expression of some individual genes in the lung and other organs
may be found in literature and public databases. In literature, newly discovered
genes have been tested in various organs at the mRNA level with Northern
blotting and RT-PCR and at the protein level with Western blotting. In public
databases, gene expression are compiled from literature, cDNA library (e.g.
UniGene) and high throughput tools such as serial analysis gene expression
(SAGE) and DNA microarray (e.g., GEO) [1]. Several studies using DNA
microarray have been reported for profiling differential gene expression among
normal human and mouse organs, but very little information is available for the
rat [2-6].
    Dual color hybridizations are commonly used for differential
expression of thousands of genes between two samples [7]. For three or more
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samples, a reference or loop design has to be employed to adapt dual color
hybridization [8,9]. In the reference design, several samples are hybridized
onto different slides separately with a common reference, which is prepared by
pooling all the samples or using genomic DNA [10]. In the loop design,
samples are paired in a loop pattern for hybridization and each sample is
hybridized twice. However, the efficiency and reproducibility of both designs
are poor for the identification of organ-prominent genes. Only two samples are
hybridized on one slide, and the hybridization on different slides is known to
have high variations due to slide printing and hybridization conditions [7]. For
instance, there are 15 pair-wise combinations among 6 distinct organs.
Consequently, 15 co-hybridizations between samples are required for a single
replication and 60 slides for an experiment with 4 biological replications.
    To eliminate these problems, we developed a parallel hybridization
system in which 6 samples can be hybridized onto one single slide. This
technique simplifies the investigation of multiple samples, reduces
experimental errors and improves experimental efficiency. Using this system,
we investigated lung-prominent genes by comparing gene expression profiles
among rat lung, heart, kidney, liver, spleen, and brain. The lung-prominent
genes identified in the present study may provide a clue for further exploration
of pulmonary functions.
3.3  MATERIAL AND METHODS
3.3.1 Microarray  Preparation
    The DNA microarray slides used in this study were in-house printed
on epoxy-coated glass slides with 50-mer aminated oligonucleotides, Pan Rat
10K Oligonucleotide Set (MWG Biotech Inc., High Point, NC). It contains 6,221
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known rat genes, 3,594 rat ESTs, and 169 Arabidopsis negative controls. The
oligonucleotides were suspended in 3x SSC at 25 µM and printed on
epoxy-coated slides (CEL Associates, Pearland, Texas) with an OmniGrid 100
arrayer (GeneMachine, San Carlos, CA) per manufacturer’s instructions. Each
oligonucleotide was spotted in triplicate on three identical 18 x 18 mm blocks:
A, B, and C (Table 3.1). The total spots on one slide were 30,000 including 186
blank spots. The spot-spot distance was 180 µm and the space between
blocks was 4 mm. The printed slides were incubated in 65% humidity overnight
at room temperature. The slides were then dried and stored in room
temperature. Prior to hybridization, the slides were washed one time with 0.2%
SDS, four times with water, and dried by centrifugation. The 3 blocks on a slide
were separated by two 2 x 25 x 1 mm thermostatic transparent tape stripes
during the hybridization. The stripes were removed after hybridization to wash
and scan slides.
Table 3.1:  Slide layout and hybridization design
Block A Block B Block CSlide Green Red Green Red Green Red
1 Lung Heart Liver Brain Kidney Spleen
2 Heart Kidney Liver Lung Spleen Brain
3 Kidney Liver Lung Brain Spleen Heart
4 Heart Brain Kidney Lung Liver Spleen
5 Heart Liver Lung Spleen Brain Kidney
The array has three identical blocks, A, B, and C; each containing 9,984 spots
representing 6,221 known rat genes, 3,594 ESTs, and 169 Arabidopsis negative controls. The
three blocks are separated with thermal plastic rings.  Three paired Cy3-(green) and Alexa
647 (red)-labeled cDNA samples were hybridized onto three blocks, A, B, and C of slide 1-5.




3.3.2 Sample collection and hybridization
    Six organs, the lung, heart, kidney, liver, spleen, and brain of male
Sprague-Dawley rats (200 g, Charles River Laboratories, Inc., Wilmington, MA)
were dissected. The organs were briefly washed with deionized water and
immediately homogenized in 10 ml TRI reagents (Molecular Research Center,
Cincinnati, OH). Total RNA was subsequently extracted according to the
manufacturer’s protocol. RNA quality and quantity were assessed by
spectrophotometer (NanoDrop Technologies, Inc, Rockland, DE) and agarose
gel electrophoresis. Total RNA samples were aliquoted (20 µg each) for cDNA
synthesis and 2-step microarray hybridization with 3DNA 50 Expression kit
(Genisphere Inc., Hatfield, PA). Briefly, total RNA was reverse-transcribed with
Cy3- or Alexa 647-specific primers. The cDNA products were purified with the
Microcom YM-30 columns (Millipore, Billerica, MA) and mixed with 2x
formamide hybridization buffer (50% formamide, 6x SSC, 0.2% SDS). The
DNA microarray slides were hybridized with the cDNA samples at 42oC for 48
hours. The slides were washed and re-hybridized with Cy3- and Alexa
647-specific capture reagents at 42oC for 2 hours. In our experiments, the
concentration of purified cDNA samples were normalized to 0.5 - 0.6 µg/µl
before hybridization. The cDNA aliquots from 6 organs of the same rat were
randomly paired and independently hybridized onto one of 3 blocks on a glass
slide. Each sample was repeated 20 times: 4 biological replications and 5
technical replications. The arrangement of samples, fluorescence dyes, and
blocks for one of the biological replications is shown in Table 3.1. The other 3
biological replications were similarly arranged in a style of random block
design. Each hybridized slide was scanned twice by a laser confocal scanner,
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ScanArray Express (PerkinElmer Life and Analytical Sciences, Boston, MA).
The first scanning was used for quantification and performed with 90% laser
power and 70~80% PMT so that about 5% spots were saturated. The second
scanning was used for spot alignment and was carried out with 90% laser
power and 95% PMT. Hybridization images were analyzed with GenePix pro 4
(Axon Instruments, Inc. Union City, CA).
3.3.3 Data analysis
Hybridization reproducibility: The reproducibility was assessed by
Pearson correlation coefficients of spot signals from self-self hybridizations.
The spot signals were background-subtracted fluorescence intensity extracted
from hybridization images by GenePix. To estimate the variations among 6
paired organs, accumulated errors of log ratios were calculated. The log ratios
between two samples were assessed from the respective spot signals,
normalized by local weighted scatter plot smooth (LOWESS) based on print-tip.






























se    (1)
Where e is the accumulated error, and
sj
silog'  are normalized log ratios
between samples s1~s6, the 6 organs arranged in a loop design. The e was
calculated in 2 groups, within-slide group and among-slide group. The log
ratios of within-slide group were obtained from one slide with 6 samples, and
those of among-slide group were from 6 slides comprised of a loop design for
6 samples.
Identification of lung-prominent Genes: To identify differentially
expressed genes among 6 organs, we first globally normalized 16-bit mean
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fluorescence intensity of each gene from original images using the software
RealSpot developed in our laboratory [12] (freely available for download for
academic usage, http://www.lungmicroarray.org). The global normalization
converted the weakest 5% fluorescence intensities to 0 (background) and the
strongest 5% fluorescence intensities to 1,000 (saturated spots, reflecting
normally scanned images). The other fluorescence intensities were scaled to
the range of 0 to 1,000. This transformation makes different slides and different
channels comparable. It is similar to Affymetrix single channel data
normalization. The transformed images and intensities were used for data
quality filters, statistics tests, and direct confirmation of the data analysis
results with spot images.
    For spot quality evaluation, a quality index (QI) was assigned to each
spot based on signal intensity and signal-to-noise ratio. QI 0-4 indicate empty,
weak, middle, strong, and saturated spots, respectively. By default, QI 0 and 4
were assigned to the empty and saturated spots, whose intensities were less
than 30% and greater than 95%, respectively. QI 1-3 was calculated, based on







= , where QIij is the
quality index of spot j on slide i and Iij the intensity of the spot j on slide i. QIij is
rounded to an integer. By default, I0 is the intensity at 30th percentile, and I1 at
95th percentile of the plot (intensity vs gene rank percentage) of the slide image.
A QI of 5 was assigned to a contaminated or bad spot based on signal
background ratio (SBR). By default, any spots with a SBR of <2.0 were given a
QI of 5. A mean quality index was calculated from the replicated spots of a
gene from multiple slides, excluding bad spots (QI=5). Data were filtered if a
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mean quality index was 1.0 or less.
    For the genes that passed the quality index filter, statistical tests were
performed. The genes with a significantly differential expression among 6
organs for at least one organ-pair were identified by a software package, SAM,
(Significant Analysis of Microarray, http://www-stat.stanford.edu/~tibs/SAM/)
[11]. The median false discovery ratio (FDR) cutoff for a multiple class
response test by SAM was set to 5%. The genes with a minimal FDR (q-value)
of >5% were discarded. The genes that passed the SAM test were further
classified into organ-prominent genes or co-expressed genes in two organs by
pair-wise multiple comparisons with Tukey’s honestly significant difference
(HSD) at an overall confidence level of 95%. Organ-prominent genes were
defined as the genes that were expressed significantly higher in one particular
organ than in other organs (p<0.05). Similarly, co-expressed genes in two
organs were defined as the genes that were expressed in the two organs than
the other 4 organs.
    To determine the relative specificity of a gene among organs, an
organ specificity index (OSI) was defined as the correlation coefficient of gene
expression levels between a gene and a putative gene. The expression levels
of a putative gene were 1,000 in prominent organs and 0 in other organs. For
example, the expression level of a putative gene prominent in the lung will be
(from left to right are lung, heart, kidney, liver, spleen, and brain) 1,000, 0, 0, 0,

























































       (2)
Where Xi and Pi are the mean gene expression levels of each organ of a gene
and the putative gene, respectively, in organ i. N is the total number of organs
(n=6 in this study).  A higher correlation coefficient indicates a higher
tendency of a gene for expression in a particular organ.
    Finally, the gene expression data were directly compared with the
respective spot images.  The spot images of the genes in each sorted data
set were searched and organized by RealSpot. The genes with visual
consistence between differential gene expression and spot images were
marked as highly prominent genes for the organ(s).  The functional categories
of these highly prominent genes were assessed based on gene ontology
annotation from Rat Genome Database gene association file (RGD,
http://rgd.mcw.edu) and gene ontology definitions (GO,
http://www.geneontology.org).
3.3.4 Real-time PCR
    Selected lung-specific genes were validated by SYBR Green I based
real-time PCR (QIAGEN, Foster City, CA) as previously described [33]. Total
RNA (5 µg) was reverse-transcribed into cDNA with 0.2 g/ l dT17, 0.3 g/ l
random hexamer primer, and MMLV reverse transcriptase (Invitrogen Inc.,
Carlsbad, CA). The primer pairs were as follows (“_F”: forward, “_R”: reverse):
beta defensin-2, BD-2_F, AAT CAC ATG CCT GAC CAA AGGA; BD-2_R, GGA
GCA AAT TCT GTT CAT CCCA; keratin19, K19_F, CCA GGT CGC TGT CCA
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CAC TAC; K19_R, CCT TCC AGG GCA GCT TTC AT; vitamin D-dependent
calcium-binding protein, Calb3_F, CAG CAC TCA CTG ACA GCA AGCA,
Calb3_R, TCC TCC TTG GAC AGC TGG TTT; surfactant protein D, SP-D_F,
TTC TCT CCA TGC TTG TCC TGC T, SP-D_R, GAC TAG GGT GCA CGT
GTT GGT T; intercellular adhesion molecule 1, ICAM-1_F, GGA GTC TCA
TGC CCG TGA AAT, ICAM-1_R, GTG CCT ACC CTC CCA CAA CA; mitogen
activated protein kinase 13, Mapk13_F, CCC AGC AGC CAT TTG ATG AT,
Mapk13_R, CAC TGC AGC TTC ATC CCA CTT; corticotropin releasing
hormone receptor, Crhr1_F, GGT CTC CAG GGT CGT CTT CAT C, Crhr1_R,
ACG CCA CCT CTT CCG GAT AG; solute carrier family 29 transporters,
member 1, Slc29a1_F, GGA CAA TGG TCT CTG ACG GAC A; Slc29a1_R,
CCT GGA ACA GGC ACA GAA GAA A; advanced glycosylation end
product-specific receptor, Ager_F, TCC GGT GTC GGG CAA CTA, Ager_R,
GGG ACA TTG GCT GTG AGT TCAG; solute carrier family 34 sodium
phosphate, member 2, Slc34a2_F, GCC CAT AGG TGT GAG CCT TTC,
Slc34a2_R, CCC CAT TCA CTC CAT CCT AGG A; lipocalin 2, Lcn2_F, TCT
GGG CCT CAA GGA TAA CAAC, Lcn2_R, AGA CAG GTG GGA CCT GAA
CCA; matrix metalloproteinase 9, MMP9_F, TGG GCA TTA GGG ACA GAG
GAAT, MMP9_R, GGG CTG TTT CCC CTG TGA GT; nucleoporin 155kd,
Nup155_F, AAG TGG ATC AAA ACC GAG TTCG, Nup155_R, TCG CTG CTG
CAG TGA AAT TTC; discoidin domain receptor family, member 2, Ddr2_F,
 AAC CAA GCA CCG ACC ATC CTT, Ddr2_R,ATG TGG CTG AGC GGT
AGG TCT T; trans-acting transcription factor 4, Sp4_F, TTG TCA CAG TTG
CCG CCA TT, Sp4_R,TGA CCA GCC CAT TTC CAG ATT T;
melanoma-associated antigen, Mg50_F, TGC CAC ATC AGT CAC CCA TGA,
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Mg50_R, AGC CGA GAC TCC AGG CTG TTT A;18S rRNA_F: TCC CAG TAA
GTG CGG GTC ATA, 18S rRNA_R: CGA GGG CCT CAC TAA ACC ATC. The
real-time PCR thermal conditions for all 14 genes listed above were 95oC 15
min, followed by 40 cycles of 95oC for 30 sec, 60oC for 30 sec, 72oC for 30 sec,
and 77oC for 35 sec. To eliminate experimental variations, all genes were
amplified in the same plate, each with 6 organ cDNA samples from one rat
(totally 84 wells for organ samples, other wells for negative controls). Three
plates were used for the three biological replications. Data were analyzed
using relative real-time PCR quantification based on the delta delta Ct method
[34]. The endogenous reference gene was 18S rRNA, and the control organ
was lung. One-way ANOVA tests were performed for statistical significance
(p<0.05).
3.4  RESULTS
3.4.1 Reproducibility and efficiency of parallel hybridization
    Our parallel hybridization system consists of three identical blocks: A,
B, and C, on a single slide (Table 3.1). Each block contains ~10,000 50-mer
oligonucleotides (6,221 known rat genes, 3,594 rat ESTs, and 169 Arabidopsis
negative controls). Six labeled cDNA samples (3 Cy3 and 3 Alexa 647) were
combined into 3 green-red pairs and hybridized onto each block of one slide.
During the hybridization step, the blocks were separated by thermostatic tapes.
The latter was removed during the washing and scanning steps. To examine
whether there was cross-contamination among blocks, blocks A and C on the
same slide were hybridized simultaneously for 3 days with Alexa 647-labeled
lung cDNA. No signals were detected in block B (data not shown), indicating
no cross contaminations among blocks.
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Fig. 3.1  Reproducibility of hybridizations. (A-C): typical scatter plots of self-self
hybridization of lung cDNAs between two channels within a block (within-block, panel A), two
different blocks in one slide (within-slide, panel B), and among slides (among-slide, panel C),
respectively. The cDNAs from an identical lung tissue were labeled with Cy3 or Alexa 647, and
hybridized to each block of the slides. The numbers on x- and y-axis were
background-subtracted fluorescence intensities of each spot with log2 transformation. (D) A
comparison of correlation coefficients from replicated hybridizations. The results were
expressed as means ± SE. *P<0.01 vs among-slide; #P<0.01 vs within-slide. (E) Comparison
of accumulated errors between within-slide and among-slide groups. For the within-slide group,
the log ratios were from parallel hybridization on a single slide. For the among-slides, the log







    Self-self hybridizations were performed on three slides to assess the
reproducibility of hybridizations using Cy3- and Alexa 647-labeled lung cDNA
samples. We observed the highest correlation coefficient between two
samples co-hybridized in one block (within-block group, Fig. 4.1A), and the
lowest one between two samples hybridized in two different blocks on two
separate slides (among-slide group, Fig. 4.1C). The within-slide group (two
samples in two distinct blocks on one slide, Fig. 4.1B) possessed a
significantly higher reproducibility than the among-slide group, but lower than
the within-block group (Fig. 4.1D, p<0.01). The lower reproducibility of the
among-slide group may be due to the experimental variations among slides,
such as hybridization temperature fluctuation, washing, and scanning. These
conditions were identical for the within-block and within-slide groups, in which
samples were hybridized in a single slide.
    Next, we investigated the relative gene expression levels in 6 rat
organs: lung, heart, kidney, brain, spleen, and liver. The hybridization of each
organ was repeated 20 times: 4 biological replications (rats), each with 5
technical replications (slides). Six samples from each of four rats were split into
5 aliquots for hybridization on 5 slides. The labeling dyes, the sample pairing,
and the hybridization blocks on a slide were randomly assigned for each
biological replication. This minimized the variations among biological and
technical replications, including animals, fluorescence dyes, sample
combinations, blocks on a slide, slides, and experimental conditions (Table
3.1). Statistically, each slide was a random block containing 6 samples. There
were 60 sample-sample hybridizations performed on 20 slides (60 Alexa
647-cDNA and 60 Cy3-cDNAs) in this experiment. To achieve similar statistical
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results, a traditional reference design requires 120 slides for co-hybridizations
of sample and reference. Alternatively, in a loop design, 60 slides are required
for co-hybridization of sample-sample.
    The difference of fluorescence intensity between the parallel
hybridization and traditional dual-color hybridization was evaluated. We first
compared the difference of log ratios between the traditional and parallel
hybridization systems by SAM [11]. The samples of lung and heart were used
as an example. The log ratios of fluorescence intensity between lung and heart
were normalized with the print-tip based LOWESS [7].  The traditional log
ratios were from 4 slides, in which lung and heart were paired and
co-hybridized onto the same block of each slide. The parallel log ratios were
from 4 other slides, in which lung and heart were hybridized onto two different
blocks of each slide. The 2-class SAM test identified no genes that showed a
significant difference between the traditional co-hybridization group and the
parallel hybridization group (false discovery ratio<0.047, q-value>0.05). Other
organ pairs showed similar results. These results demonstrated that the log
ratios of two samples from two different blocks in the parallel hybridization
were not significantly different from that of the traditional two sample
co-hybridization. Consequently, any two of the six samples hybridized onto
one slide in the parallel hybridization can be directly compared as if these
samples were pair-wise combined and co-hybridized onto one traditional slide.
    We also tested the accumulated error of the log2 ratios among 6
organs. In a traditional loop design, the sum of log ratios along the loop should
be zero, but frequently fluctuating. Therefore, the square sum of log ratios can
be adapted to assess the accumulated error of each gene or the data
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fluctuation in one experiment. We selected one block from each of the six
different slides and simulated the traditional loop design. The 6 blocks formed
a loop as if they were 6 traditional co-hybridization slides. In another group, a
loop was formed from a single parallel hybridization slide. The slides for both
groups were randomly selected. The accumulated errors were calculated as
described in the Materials and Methods, followed by being sorted ascending,
and plotted against ranked genes. We found that 21% of the genes showed an
accumulated error of >5 in the traditional hybridization group, but only 4% in
the parallel hybridization group (Fig. 4.1E). A paired t-test of the accumulated
errors between the two groups revealed that the fluctuation of the traditional
co-hybridization was significantly higher than that of the parallel hybridization
(p<0.05).
3.4.2 Prominent genes expressed in the lung
  Lung-prominent genes were identified through quality filter, statistics
filter, and image confirmation. Several steps of data analysis were followed
(see Materials and Methods for details): (i) After hybridization, we first checked
the qualities of whole hybridization images and excluded the images from poor
slides (one out of 20 slides was discarded); (ii) We filtered 2,829 low quality
spots based on a mean quality index of <1 as our quality filter; (iii) Statistics
test using SAM analysis revealed that the expression levels of 3,576 genes
were significantly different among 6 organs (false-positive ratio <5%, and
median false discovery ratio <0.05); (iv) In order to identify organ-prominent or
co-expressed genes, the genes passed SAM test were further analyzed by
multiple comparisons using Turkey’s honestly significant difference (HSD)
tests at an overall confidence level of 95%. Organ-prominent genes are
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defined as genes that are expressed significantly higher in one particular organ
than any other organs (P<0.05). Similarly, co-expressed genes are the genes
that are expressed significantly higher in two organs than any other 4 organs
(P<0.05). There were some duplicated genes in single and two
organ-prominent groups. The duplicated genes with a lower OSI were filtered.
The duplication was due to the HSD-based multiple comparisons. For instance,
endothelial cell growth factor protein precursor (VEGF, Genbank ID:
NM_031836) was expressed significantly higher in the lung than other organs
(p<0.05, OSI for lung=0.975). This gene was also co-expressed significantly
higher in the lung and the liver than in other organs (p<0.05, OSI for lung and
heart=0.778).  In this case, we thus deleted this gene from the lung-liver
group;  (v) Finally, we further verified the genes identified above by directly
comparing the results with spot images in a spreadsheet using the RealSpot
software [12]. The visually inconsistent genes with spot images were filtered.
The final genes were summarized in Fig. 4.2 and the hot maps of these genes
were shown in Fig. 4.3. The liver showed the highest number of prominent
genes (306 genes) and spleen the lowest (75 genes). The numbers of other
organ-prominent genes were brain (218), kidney (163), lung (147), and heart
(95). The lung had a high number of co-expressed genes with other organs:
lung-spleen (203), lung-heart (23), lung-liver (37), lung-kidney (98), and
lung-brain (10). The kidney also had a high number of co-expressed genes,
kidney-liver (151) and kidney-brain (19). A list of all the organ-prominent genes
is given in Additional file 1 (Supplementary Table E1, the excel format to show
gene expression data) and Additional files 2 and 3 (Supplementary Table E2A
and E2B, the PDF format to show spot images).
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        The prominent genes for one or two organs were further classified
into 4 functional categories: function unclear, cellular location, molecular
function, and biological process, using ontology annotations from Rat Genome
Database (http://rgd.mcw.edu) and Gene Ontology
(http://www.geneontology.org). The main functional categories of prominent
genes were summarized in Additional file 4 (Supplementary Table E3) for one
organ and in Additional file 5 (Supplementary Table E4) for two organs. The
functions of the lung-prominent genes include ligand binding, signal transducer,
cell communication, development, and metabolism. The cellular location was
omitted since only a few genes were documented at the sub-cellular level. It is
worthy to note that the functions of 60% or more genes we identified remain
unclear in the present time.
Fig. 3.2: Summary of differentially expressed genes among 6 organs. The number under
an organ represents the genes that are expressed significantly higher in the respective organ
compared to other organs (p<0.05). Similarly, the number between any two organs represents
the genes that are expressed significantly higher in the two organs compared to other organs
(p<0.05). Thicker lines highlight a larger number of the genes co-expressed in the respective
two organs.
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3.4.3 Real-time PCR verification
    Based on our research interests, we focused on lung-prominent
genes for real-time PCR verification. We selected genes based on both mRNA
abundance (signal intensity) and organ specificity index (OSI). OSI was
defined as the correlation coefficient of expression levels between an
interested gene and a putative gene that had 100% specificity (see Materials
and Methods). The known lung marker genes have high OSIs, e.g. T1 , 0.996;
SP-A, 0.993; SP-D, 0.993; SP-B, 0.933; CCSP, 0.972; and SP-C, 0.912
(Additional file 1). We chose 13 genes, which ranked in the top 30% in signal
intensity (high expression level) and the top 10% in OSI (high specificity). In
addition, we selected 3 genes that ranked below 30% in signal intensity (low
expression level). Real-time PCR verified 13 genes that were expressed
significantly higher in the lung than in other organs (Fig. 4.4). These genes
include BD-2, K19, Calb3, SP-D, ICAM-1, Mapk13, Crhr1, Slc29a1, Ager,
Slc34a2, Lcn2, Ddr2, and Mg50. Furthermore, the expression level for most of
the genes in the lung was 10 times or more as high as that in other organs.
The expression pattern of these genes was consistent with DNA microarray
signals (Table 2). Three genes, Nup155, MMP9 and Sp4, did not show a
significantly higher mRNA abundance in the lung when compared to other
organs under our experiment conditions. This is due to high variations between
samples.
3.5  DISCUSSION
    In the current study, we developed a parallel hybridization, in which 6
samples can be hybridized onto one single slide. This method provides higher
reproducibility and efficiency than the standard co-hybridization, and should be
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suitable for experiments investigating multiple biological samples. Using this
system, we identified genes prominently expressed in one or two organs of the
rat lung, heart, kidney, liver, spleen, and brain. Thirteen out of 16 selected
lung-prominent genes were verified by real-time PCR. The genes identified in
present study may be useful for further functional investigation in the lung or
other organs.
    The organ-prominent genes we identified were directly based on statistical
comparisons of normalized spot signals. These genes were further ranked by
organ specificity index (OSI). The “standard” DNA microarray data process
extracts fluorescence intensities of both channels from hybridization images,
and calculates and normalizes ratios for further statistical analysis. Our
method is different from the “standard” analysis in several ways: (i) we linearly
transformed all of the spot signals from each channel of hybridization images
into a 0-1,000 scale, which made different channels and slides comparable.
Unlike the ratio normalization, we retained relative expression levels in each
channel. This is especially useful for multiple sample comparisons; (ii) Gene
classification was based on multiple comparisons. Differentially expressed
genes among the 6 organs were identified from SAM test, followed by multiple
comparison using Tukey’s HSD; and (iii) we ranked the genes by organ
specificity index (OSI), higher OSI, more specific a gene in one or two organs.
In this investigation, we selected lung-prominent genes for verification based
on the combination of OSI and normalized spot intensity. We chose the genes
ranked in the top 10% in OSI and the top 30% in spot intensity, which ensures
both the lung-specificity and the gene expression level.
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Fig. 3.3: Hot maps of Organ-prominent genes. Left and right panels are the relative
expression levels of genes differentially expressed in one and two organs, respectively.  Each
column represents 19 replicated hybridizations of each organ and each row shows the spot
signals of the organ-prominent genes. The scale of normalized spot signals was indicated on
the top of the graph. (A): lung: 166 genes; (B) heart: 100 genes; (C) kidney: 186 genes; (D)
liver: 324 genes; (E) spleen: 88 genes; (F) brain: 225 genes; (G) lung-heart: 47 genes; (H)
lung-liver: 33 genes; (I) lung-spleen: 95 genes; (J) kidney-liver: 174 genes; (K) lung-kidney: 21























BD-2 K19 Calb3 SP-D ICAM-1 Mapk13 Crhr1
Slc29a1 Ager Slc34a2 Lcn2 ddr2 mg50
Fig. 3.4  Relative mRNA abundance of lung-prominent genes determined by
relative real-time PCR  The mRNAs from six organs were reverse-transcribed to cDNA and
quantified by relative real-time PCR. All of the genes were run on the same plate with 18S
rRNA as an endogenous reference. The results were expressed as % of lung.  Data shown
are means ± S.E. (n=3 biological replications).The mRNA expression level of all the genes in
the lung was significantly higher in other organs (P<0.05).
    Recently, several studies have compared gene expression profiles in
human and mouse [2-6]. Only one report was done on rats with a focus on the
brain using commercial Affymetrix chips (7,000 known genes and 1,000 ESTs)
[6]. In this data set, the lung and liver were not included and only two
replications for the spleen, heart, and kidney were used. In comparison, 2,426
genes out of the 3,576 differential genes (current study, without image-filter)
were found to be common with the Walker’s study [6]. The correlation
coefficient of relative expression between the two data sets was around 0.4 for
heart, kidney, or spleen. The low quantitative correlation may be due to the
differences between Affymetrix and our in-house microarray platforms such as
glass slide/silicon wafer, two/one channel, and 50-mer oligonucleotide/25-mer
oligonucleotide set. However, the two data sets showed a consistent gene
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expression pattern among heart, kidney, and spleen, when we manually
compared differential expression of the genes with top OSI for each pattern.
We also compared our dataset with other published datasets from other
species that list lung-specific genes. The dataset
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2361 and
http://www.genome.rcast.u-tokyo.ac.jp/normal/) listed 43 human lung-specific
genes. Many known lung-specific genes such as T1 , caveolin and CCSP
were not on this list. Among 43 genes on the list, 18 genes were found in our
list of lung-prominent genes, including known lung-specific genes, surfactant
proteins, ager and a verified gene, Slc34a2.  The published dataset was
based on a single hybridization of normal lung tissue. Our lung-prominent
genes were based on 20 replicated DNA microarray hybridizations (4
biological and 5 technical replications). We believe that our gene lists were
statistically confident and had a lower false-positive or false-negative genes.
The 13 lung-prominent genes we verified by real-time PCR have various
functions, including pulmonary defenses, ion/solute transport, hormone
receptor, differentiation, oxidant response and tumorgenesis. Five of them are
defense genes. BD-2 ( -defensin 2) is a cationic peptide with a
broad-spectrum antimicrobial activity and contributes to innate immunity in the
lung [13]. It is expressed in the airway epithelia [14]. BD-2 was increased in the
patients with inflammation and infections [15,16]. SP-D (surfactant protein D) is
highly expressed in alveolar epithelial type II cells and plays a pivotal role in
cell defense against microbes [17,18]. For instance, it has been reported that
SP-D inhibited the proliferation of bacteria by increasing the permeability of the
microbial cell membrane. ICAM-1 (intercellular adhesion molecule 1) is a cell
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adhesion molecule and a ligand for leukocyte adhesion molecule LFA-1.
ICAM-1 also participates in the inflammatory response to
lipopolysaccharide-induced lung injury by interacting mainly with neutrophils
[19]. Lipcocalin 2 (also known as 2u-globulin-related protein, X13295) is a
member of lipocalin protein family composed of small secreted proteins that
have the ability to bind to small hydrophobic ligands [20]. Lipocalin 2
expression in the lung is markedly increased in acute lung injury caused by
diesel exhaust particles and lipopolysaccharide [21]. Mapk13 (mitogen
activated protein kinase 13) plays a role in stress and inflammatory responses
via the MAPK cascade signaling pathway. Mapk13 is predominantly expressed
in the lung although a small amount of Mapk 13 is also present in kidney [22],
which is consistent with our results (Fig. 3.4).
    Three of the identified lung prominent genes are ion/solute
transporters. Calb3 (Calbindin 3), a vitamin D-dependent Ca2+ binding protein,
was previously studied in the intestine, uterus, placenta, and lung epithelium
[23]. It is a Ca2+ transporter and regulates Ca2+ homeostasis. Slc29a1 (solute
carrier family 29 transporter, member 1) is an equilibrative
nitrobenzylthioinosine-sensitive nucleoside transporter (ENT1), which
transports nucleosides into or out of the cells in a Na+-independent manner
[24]. Northern blot analysis has shown that Slc29a1 is highly expressed in the
lung and testes [25]. It plays a role in nucleotide biosynthesis and cellular
signaling. Slc34a2 (solute carrier family 34 sodium phosphate, member 2) is a
sodium dependent phosphate transporter. It has been shown that Slc34a2 was
predominantly expressed in the lung and in situ hybridization revealed that it is
localized in alveolar type II cells [26]. Slc34a2 provides inorganic phosphate for
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the synthesis of lung surfactant.
Table 3.2 DNA microarray signal intensities and spot images of 13 verified genes*
* Gene ID: Genbank accession number; GeneName: name and common symbol of a gene;
signals: mean scaled fluorescence intensity of brain, heart, kidney, lung, and spleen; the error
bars were based on standard deviation. OSI: Organ specific index (see text for detail)
    Crhr1 (corticotropin releasing hormone receptor 1) is a receptor that
binds corticotropin-releasing hormone. The mice null for the crhr1 gene died
within 48 hours after birth because of a pronounced lung dysplasia [27].
Interestingly, variation of Crhr1 was associated with improved function in the
asthma patients who were treated with inhaled corticosteroids [28].  K19
(keratin 19) is expressed in epithelial cells, involved in testicular differentiation
and lung cancer [29,30]. Ager (advanced glycosylation end product-specific
receptor) is a member of the immunoglobin superfamily and is involved in
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oxidant response. It is specifically expressed in alveolar epithelial type I cells
[31]. Lung type I cells are squamous, covering >90% of alveolar surface, and,
thus, are easily damaged by oxidants. Ager may protect lung type I cells from
oxidative injury.
Table 3.3  Gene functions in the lung and 2nd organ
Gene Function in lung 2nd organ
(location)
Function in 2nd organ
Ager Oxidant response (AEC I)*
ICAM-1 AEC-leukocyte adhesion (AEC)
K19 Cell differentiation (AEC)
SP-D, BD-2 Defense, surfactant (AEC II)








Tnni2, tni3 Lung veins [35] Heart Muscle contract [36,37]
Cox6a2, Cox8h Energy supply? Heart Muscle energy supply [38]
[39]
Anp Asthma? [40] Heart Proliferation control [41]
Aqp5 Edema? Liver Fluid homeostasis [42]
Ces3,gpt Injury and repair [43] [44] Liver Injury [45]
Cyp2615 Oxidantive stress [46] Liver Xenobiotic metabolism?
Cldn3 Epithelia barrier [47] Liver Paracellular permeability
[48]
S100a18 Cell migration [49,50] Spleen Cell motility?
Iga, Igm [51] [52] Immune response Spleen Immune response
Cd37 [53] Proliferation? Spleen Proliferation?
Cathepsin Y Surfactant process? [54] [55] Spleen Endopeptidase [56,57]
Fas, Alp AEC II injury [58] Kidney Renal injury [59] [60]
Tpa66 Inflammatory[61] Kidney Anti-arterial thrombosis[62]
Nf2 [63] Tumor supression Kidney Tumor suppression
* AEC I and II: Alveolar epithelial type I and II cells. See the main text for more references.
? Hypothesized function
     The two lung-prominent genes with lower mRNA abundance, Ddr2
and Mg50, may be involved in human tumorgenesis
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&do
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pt=Abstract&list_uids=15111304&query_hl=1), and the regulation of collagen
remodeling in the lung
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&do
pt=Abstract&list_uids=11103812&query_hl=11).
    The functions of 13 verified genes as well as some highly abundant
co-expressed genes in the lung and another organ were summarized in Table
3.3.  These co-expressed genes were previously studied in the lung or
another organ. The most prominent genes expressed in the lung were relevant
to pulmonary protection, including oxidant response, injury and repair,
inflammatory, cell defense, and immune response. These genes also
contribute to organ construction such as lung veins, energy supply, and
epithelial tight junction. Some of these genes may be important for cell
proliferation, such as anp and nf2. Two genes, anp and aqp5 may play a role in
asthma and edema, respectively. The function of cd37 is currently unclear in
any of the organs. Its prominent and specific expression in the lung may imply
its important role for lung function. Cd37 may participate in cell proliferation in
the lung based on the studies from other members of this gene family. Similarly,
cathepsin Y may play a role of surfactant protein processing or apoptosis
considering its endopeptidase activity in the spleen and the functions of
cathepsin D and H in the lung. These hypothesized functions may serve as a
starting point for further functional studies in the respective organs.
    The parallel hybridization system has several advantages over the
traditional two-color hybridization. First, in this hybridization system 6 paired
and dual-color labeled samples were hybridized onto one slide and scanned
under identical conditions. The homogenous conditions on one slide improved
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the reproducibility and decreased the variation, especially accumulated
experimental errors. The latter is problematic in microarray experiments
involving a series of samples such as a time course study. Second, any two of
the six samples in a parallel hybridization can be directly compared; whereas
only two paired samples can be directly compared in the traditional two-color
hybridization of a reference or loop design. This increases the experimental
efficiency and reduces the number of slides and the amount of RNAs in a
whole experiment. In the parallel hybridization system, only one slide is
needed for six samples.  In contrast, 6 slides are required for a reference or
loop design of six samples in the traditional two-color co-hybridization. The
RNA amount is reduced to half that of the traditional hybridization. This is
because each sample needs to hybridize twice with neighboring samples in
the loop design or hybridize to a common reference consisting of all the
samples in the reference design. Multiple-color hybridization on one slide
could be developed for three or more samples labeled with distinct
fluorescence dyes. However, the potential cross-talk among fluorescence dyes
and the need for multiple lasers of a scanner limit its application.
The organ-prominent genes in the current study were identified from 6
organs. Some of them may be expressed higher in other tissues outside the 6
organs we monitored. This limitation may be overcome by further improvement
of the parallel hybridization system. One possibility is to include one common
control organ (e.g. lung) in all of the parallel hybridization slides. Although it
reduces the efficiency, the transcriptomes of more than 6 organs can be
directly compared. Another possibility is the potential technical improvement of
spot printing and sample arrangement, which may result in more than 6
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samples on one parallel slide. In the present study, we printed 10K rat genes in
triplicate on three blocks on one slide. Each block contains 16 sub-arrays (4.5
x 4.5 mm) consisting of 625 genes. Therefore, 6 samples can be hybridized to
10K genes in this system. If we print 625 genes onto 48 sub-arrays in replicate,
96 dual-color labeled samples can be hybridized on one slide. Furthermore, if
we increase the printing resolution from 160 to 80 microns, we can print 2,500
spots on one sub-array. Consequently, 96 samples can be hybridized to one
slide containing 2,500 genes. Another improvement may be the separation of
the slide regions. We used thermostatic tapes to divide 3 blocks, which may
not be appropriate for more samples. The chambered coverslips of 24 or 48
wells such as CultureWell™ coverslip system or array of arrays glass wafer [32]
may be adapted for this purpose.
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Alveolar Type I Cells Protect Rat Lung Epithelium from Oxidative Injury7,8
4.1  Abstract
The lung alveolar surface is covered by two morphologically and
functionally distinct cells: alveolar epithelial type I and type II cells (AEC I and II).
The functions of AEC II, including surfactant release, cell differentiation, and ion
transport, have been extensively studied. However, relatively little is known
regarding the physiological functions of AEC I. Using DNA microarray based
gene expression profiling, we detected the expression of many type I
cell-specific genes with a diversity of functions, including cell defense from
freshly isolated AEC I and II. Nine out of 10 selected genes that are
differentially expressed in AEC I were verified by quantitative real-time PCR.
Two genes, apolipoprotein E (Apo E) and transferrin were further
characterized and functionally studied. Immunohistochemistry indicated that
both proteins were specifically localized in AEC I. Up-regulations of Apo E and
transferrin were observed in hyperoxic lungs. Functionally, Apo E and
7 Contributions of co-authors: Jiwang Chen and Zhongming Chen contributed equally to this
chapter. Jiwang Chen prepared AEC I and AEC II, and performed immunohistochemistry; Nili
Jin and Jiwang Chen performed real-time PCR, Telugu Narasaraju performed hyperoxia
exposure, Narendranath Reddy Chinagari performed animal study, Lin Liu is the principle
investigator.
8 Our microarray dataset has been submitted to GEO and can be accessed by following
steps: 1. Go to webpage http://www.ncbi.nlm.nih.gov/projects/geo/;
2.   Go to the bottom of this page;
3. Login to GEO; a. user: zhongmingchen; b. password:123456; c. Click  button “Login”;
4. Go to our data set; a. GEO accession: GPL1699; b. Click button “GO”;
5. View dataset by click hyperlinked items of “Sample id”
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transferrin play protective roles against oxidative stress in an animal model.
Our studies suggest that AEC I is not just a simple barrier for gas exchange,
but a functional cell that protects alveolar epithelium from injury.
4.2  Introduction
AEC II are cuboidal in size and only occupy ~5% of the lung alveolar
surface area. They synthesize, secrete and recycle lung surfactant. They also
trans-differentiate to AEC I to repair the alveolar epithelium after lung injury or
during normal fetal lung development (Fehrenbach, 2001). In contrast, AEC I
are squamous in shape and cover ~95% of the surface area of the lung.
Traditionally, AEC I are thought to simply function as a barrier for gas
exchange. Because of the difficulties in the isolation and culture of AEC I,
relatively little was known regarding the functions of AEC I (Williams, 2003).
Earlier studies have reported methods to isolate AEC I (Weller & Karnovsky,
1986;Picciano & Rosenbaum, 1978). Recently, several laboratories improved
the isolation protocols and obtained relatively pure AEC I (Chen et al.,
2004a;Dobbs et al., 1998;Borok et al., 2002). More studies on the identification
of AEC I markers (Chen et al., 2004b;Qiao et al., 2003;Gonzalez et al.,
2005;Dahlin et al., 2004) and the physiological functions of AEC I (Johnson et
al., 2002;Borok et al., 2002;Ridge et al., 2003) were performed.  AEC I is
highly water-permeable and may be responsible for the high water permeability
between the alveolar airspace and the blood vessels  (Dobbs et al., 1998). The
epithelial Na+ channel and Na+-K+-ATPase have been identified in AEC I,
indicating its participation in ion and fluid transport in the lung (Borok et al.,
2002;Johnson et al., 2002;Ridge et al., 2003). In this study, we performed DNA
microarray analysis of AEC I and AEC II. Further characterization and
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functional studies revealed that apolipoprotein (Apo E) and transferrin were
specifically synthesized by AEC I in the lung, suggesting that AEC I may
function as protective cells to prevent alveolar epithelium from oxidative injury.
4.3  Materials and Methods
4.3.1 Microarray printing and hybridization - The Pan Rat 10K
Oligonucleotide Set (MWG Biotech Inc., High Point, NC) contains aminated
50-mer oligonucleotides representing 6,221 known rat genes (4,825 Unigene
entries), 3,594 rat ESTs, and 169 Arabidopsis negative controls. The
oligonucleotides were suspended in 3x SSC at a final concentration of 25 µM
and printed on epoxy coated slides by an OmniGrid 100 arrayer
(GeneMachine Inc., San Carlos, CA). Each oligonucleotide was spotted in
triplicate in three identical 18 x 18 mm blocks: A, B and C. The spot-spot
distance was 160 µm and the space between blocks was 4 mm. The printed
slides were air-dried and stored in room temperature until hybridization.
Randomly selected 2 slides from each print batch were stained with SYBR
green II for quality test and were shown a uniform spot morphology.
Total RNA was extracted from AEC I and AEC II with TRI reagents
(Molecular Research Center, Cincinnati, OH). The RNA samples (3 g each)
were reverse-transcribed into cDNA with Alexa 546 (green)- or Alexa 647
(red)-specific primer of the 3DNA 350 expression kit (Genisphere Inc., Hatfield,
PA), purified with Microcom YM-30 columns, and mixed with 2x formamide
hybridization buffer (50% formamide, 6x SSC, 0.2% SDS, and 10x Denhardt
solution) in an equal amount. The green-red color paired cDNA sample was
denatured at 80oC for 10 min and added to a DNA microarray slide pre-washed
with 0.2% SDS. An additional slide was face-to-face covered on this slide as
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cover slip. To eliminate the fluorescence dye-induced bias, dye-flip was
applied from different sample preparations. The slides were incubated at 42oC
for 48 h, followed by washing and hybridizing with Alexa 546- and Alexa
647-labled dendrimers. Hybridized slides were scanned twice (55% PMT and
90% PMT with 90% laser power) with ScanArray Express scanner
(PerkinElmer Life and Analytical Sciences, Boston, MA).
4.3.2 Data analysis - Hybridization images were analyzed by Software
package GenePix pro 4 (Axon Instruments Inc, Union City, CA). The 90% PMT
images were used for the alignment of spots with microarray grids and the
50% PMT one for raw data extraction and subsequent analysis. log2 ratios of
AEC I to AEC II were calculated from the background-subtracted mean
fluorescence intensities of the respective spots and normalized by local
weighted scatter plot smooth (LOWESS) based on print-tip. The quality of
each spot was evaluated based on spot morphology and quality index (0~4)
assigned by software package RealSpot developed in our lab (Chen & Liu,
2005). The quality indices of each gene from replicated hybridizations were
averaged. The genes with an average quality index of 1.0 or less were filtered
and excluded from further analysis. The differentially expressed genes
between AEC I and AEC II were identified by significance analysis of
microarray (SAM) (false discovery rate<0.01, q-value<0.01)
(http://www-stat.stanford.edu/~tibs/SAM/). The identified differential genes
were visually validated with spot images using RealSpot. The genes with
inconsistent spot images were filtered. Then, the genes were functionally
grouped by gene ontology annotation (http://www.geneontology.org and
http://www.rgd.mcw.edu). The identified genes with a 2 fold change or higher
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were listed in Supplementary information, Tables S1 and S2 online.
Additionally, relative gene expression levels were assessed by signal rank in
10K gene list. The gene with the highest signal was ranked 1, and lowest
ranked 10,000. The rank average of a gene in AEC I or AEC II was considered
as the relative expression level in the respective cell type.
4.3.3 AEC I and AEC II isolation - AEC I and AEC II were isolated from
male Sprague-Dawley rats around 250 g according to our recently developed
method (Chen et al., 2004a). Briefly, normal rats were anesthetized with
intraperitoneal injection of ketamine (40 mg/kg) and xylazine (8 mg/kg).
The rats were killed by bleeding through artery after fully numbed. The
lungs were perfumed to remove blood cell and removed from rats by
surgical procedures (approved by the animal care committee, Oklahoma
State University). Sequentially, the lungs were lavaged, digested with
elastase, chopped, filtered, plated in rat IgG coated culture dishes to
remove macrophages, and negatively selected with rat IgG-, CD4- and
T1 -conjugated Dynal-bead to further remove macrophages,
lymphocytes and AEC I. The purities of the final AEC I and AEC II
preparations were >90% and >96% as assessed by immunocytochemistry
using anti-T1  antibodies (E11, a kind gift of Dr. Mary Williams, Boston Univ.
and Dr. Antoinette Wetterwald, University of Berne) and the surfactant protein
C antibodies (for methodology establishment, and Papanicolaou staining for
routine purity assessment), respectively. Cross-contaminations of AEC I and
AEC II were less than 0.5%. The viabilities of both cell preparations were
>95% as determined by trypan blue dye exclusion.
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Table 4.1 Primers used for quantitative real-time PCR
Gene name GenBankID Forward primer Reverse primer
WAP four-disulfide core





Alpha-b-crystallin B M55534 CAGGAAGATTCCAGCCTCTG
GTTCTCTGGAGCCA
GGACAG



















































4.3.4 Quantitative real-time PCR - Data validation of DNA microarray
hybridization was performed by quantitative real-time PCR using QuantiTect™
SYBR® Green PCR kit as previously described (Chen et al., 2004b). Primers
were listed in Table I. PCR amplification was performed on ABI PRISM 7700
(Applied Biosystems, Foster City, CA). PCR products were purified with
GENECLEAN Turbo for constructing standard curves (10~109 copies). All
gene copy numbers were normalized to 18S rRNA.
4.3.5 Immunohistochemistry – This was performed as previously
described (Narasaraju et al., 2003). Antigen retrieval was carried out by boiling
the sections in microwave for 5 min in 20 mM citrate buffer (pH 6.0) before
permeabilization. Primary and secondary antibodies were goat anti-Apo E
(1:100, Santa Cruz), rabbit anti-transferrin (1:200, Research Diagnostics),
mouse anti-transferrin receptor (1:200, BD Biosciences); mouse anti-LB-180
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(1:100, Covance, Richmond, CA); mouse anti-T1  (E11, 1:100);
Cy3-conjugated anti-mouse or Alexa 488-conjugated anti-goat antibodies
(1:500).
4.3.6 Western blot - This was done according to our previous protocols
(Narasaraju et al., 2003). Primary antibodies used include: goat anti-Apo E
(1:500), mouse anti-basigin (1:1000, BD Biosciences), mouse anti-CD9
(1:1000, Developmental Studies Hybridoma Bank, Iowa), mouse anti-Sparc
(1:1000, Developmental Studies Hybridoma Bank, Iowa), rabbit anti-transferrin
(1:1000), rabbit anti-alpha-b-crystallin (1:200, Covance), and anti-  actin
(1:4000, Sigma, St. Louis, MO) antibodies.  Secondary antibodies were
HRP-conjugated anti-goat IgG (1:5000) or HRP-conjugated anti-mouse IgG
(1:10000).
4.3.7 Hyperoxia model of rat lung injury - Pathogen free male
Sprague-Dawley rats (~ 250 g) were used for animal studies. Oklahoma
State University Animal Use and Care Committee approved all animal
surgeries and exposure of rats in 95% or higher oxygen for up to 72 hours
used in this study. Totally, 20 rats were exposed in the present study.
Transferrin (1 mg/rat, Research Diagnostics, Inc), Human recombinant
Apo E2 (50 g/rat, Pan Vera Corporation, Madison, WI) and BSA (1 mg/rat)
were intratracheally delivered into rat lungs. The treated rats were
placed in a sealed Plexiglas chamber (90 x 45 x 45 cm) and exposed to
>95% oxygen for 48, 60 or 72 hours. The flow rate was maintained at 10
L/min. The oxygen concentration was continuously monitored with an
oxygen sensor (Vacu-med, Ventura, CA). Rats had free access for food
and water. After a 60 hours exposure, rats were anesthetized with
91
intraperitoneal injection of ketamine (40 mg/kg) and xylazine (8 mg/kg).
Pleural fluid was collected with 1~1000µl pipette and 1ml tips before the
lungs were perfused with 50 mM phosphate buffered saline (pH 7.4).
The volume of pleural fluid from each rat was measured with 1000µl
pipette and recorded. Lungs were lavaged with 7 ml of normal saline for
three times. Lavage solution (21 ml) was centrifuged to remove the cells
and was concentrated to the same volume for western blot analysis.
4.4 Results and Discussion
To explore specific gene expressions and their potential functions in
AEC I, we performed DNA microarray analysis using freshly isolated rat AEC I
and AEC II (DNA microarray data have been submitted to GEO database:
http://www.ncbi.nlm.nih.gov/geo/submission/login/, user name=
zhongmingchen, password= 123456, Series entry = GSE2160). The purities of
our AEC I and AEC II preparations were >90% and >96%, respectively, and the
viabilities were >95%. The cross-contaminations between two cell preparations
were <0.5%. The isolated cells have typical characteristics of the in vivo lung,
remaining functional and suitable for culture (Chen et al., 2004a). We used 5
independent preparations of AEC I and AEC II isolated from adult male rats for
microarray analysis and 6 technically replicated hybridizations performed for
each preparation, i.e., each labeled AEC I-AEC II cDNA was hybridized on two
slides (a slide and its cover slide), on which each gene had 3 replicated spots
and totally 6 spots per gene. Dye-flip was applied to dual-color microarray
hybridizations of the 5 preparations AEC I vs. AEC II (i.e., Alexa 546-AEC I vs.
Alexa 647-ACE II and Alexa 647-AEC I vs. Alexa 546-ACE II were alternatively
used), to eliminate the bias resulted from the fluorescence dye during the
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image scanning step. After data filter, LOWESS normalization, and statistical
SAM test, 2,222 known genes or ESTs in our 10K microarray were significantly
and differentially expressed in AEC I or AEC II (p<0.01); 1,080 were expressed
higher in AEC I and 1,142 higher in AEC II (Fig. 4.1a). The number of
differentially expressed genes in AEC I or AEC II was similar due to the ratio
centering during LOWESS normalization. Among the 1,265 known genes
excluding ESTs, there were 498 for AEC I and 767 for AEC II. To select genes
for further study, especially for validation with real-time PCR, the 1,265 known
genes were grouped in fold changes and relative gene expression rank (Fig.
1b & 1c). More genes were differentially expressed in AEC I than AEC II when
the fold change decreased. For instance, 109 genes for AEC I and 87 for AEC
II exhibited a fold change of  2. The differentially expressed genes were
distributed in all the gene expression levels (rank meaning: 1 ~ 500 were
highly expressed genes, 500 ~ 1500 middle, 1,500 and 4,000 weak, and
4,000~10,000 not visually detectable). Genes differentially (2 or more fold
changes) and highly (ranked 1~500) expressed in AEC I were considered to
be further investigated.
 Gene ontology annotations were another consideration for further targeting
novel genes that may essential for AEC I.  The differentially expressed genes
were split into functional groups using the information from Rat Genome
Database GO association (RGD, www.rgd.mcw.edu) and gene ontology
definitions (http://www.geneontology.org). RGD annotated 893 out of the1,265
differentially expressed genes in AEC during the manuscript preparation, 327
for AEC I, and 566 for AEC II. The main gene groups were listed based on GO
categories (Table II). In our gene list, each gene was assigned about 5 GO IDs,
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which reflected the multiple functions of most of the known genes.
Consequently, the total gene number from all the GO categories was larger
than 893, the actually annotated genes in our data set. A high percentage of
the differentially expressed genes observed for membrane or nucleic proteins
(57%, based on GO categories in table II, instead of the actual genes. Other
percentages were similar), but relatively less in cytoplasm (31%) or
extracellular space (12%). On the other hand, AEC I had more mitochondrial
proteins (26 genes) than AEC II (20 genes). Functionally, many of these genes
were related to known AEC functions such as phase II xenobiotic metabolism
(transferase activity), oxygen metabolism (oxidoreductase activity) and fluid
transport (ion channel activity). Other major functions included gene regulation
(DNA binding, transcription factor activity, and RNA binding) and signaling
pathways (calcium ion binding and G-protein coupling receptor activities).
We next focused on the AEC I-specific genes based on the above
information of fold-change, rank and GO annotation. Further characterization
and functional studies of these genes are not only able to identify AEC I
markers, but also provide clues for potential functions of AEC I. Many known
AEC I markers such as caveolin-1  (5.90 ± 1.21), caveolin-1  (4.11 ± 1.22),
T1  (3.78 ± 1.08), and aquaporin 5 (4.99 ± 1.08) were shown to be
differentially expressed in AEC I in our 10K microarray data set (ratio of AEC I
vs. AEC II, means ± SE, for a complete list of AEC I and AEC II genes, see
Supplementary information, Table S1 and S2 online).
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Fig. 4.1  DNA microarray analysis of alveolar epithelial type I and type II cells (AEC I
and AEC II).  Freshly isolated AEC I and AEC II were subjected to 10 K rat DNA microarray
(~6,000 known genes and ~ 4,000 EST) analysis. There were 5 biological replications and 6
technical replications (2 slides, 3 replicates on one slide). Total replications were 30 for each
gene.  (a) gene numbers during different stages of data analysis. (b) fold change distributions
of differentially expressed genes in AEC I and AEC II. (c) Relative expression levels of
differentially expressed genes as shown in expression ranks. Data present ranks ± SE
(1~10,000) of gene expressions based on 10 K genes, each with 30 replicated spots. Left four
panels show rank plots with fold changes of 1-1.5, 1.5-2, 2-2.5 and >2.5, and right panel all of
the differentially expressed genes.

































Table 4.2 Functional groups of differential genes between AEC I and AEC II
GO ID Meaning Total AEC I AEC II
Cellular location
GO:0016021 integral to membrane 191 67 124
GO:0016020 Membrane 119 46 73
GO:0005634 Nucleus 108 25 83
GO:0005615 extracellular space 88 31 57
GO:0005622 Intracellular 46 14 32
GO:0005739 mitochondrion 46 26 20
GO:0005737 Cytoplasm 29 12 17
GO:0005576 extracellular 25 5 20
GO:0005783 endoplasmic reticulum 25 14 11
GO:0005840 Ribosome 24 9 15
GO:0005856 cytoskeleton 17 7 10
GO:0005794 Golgi apparatus 14 7 7
Function
GO:0016787 Hydrolase activity 73 35 38
GO:0016740 transferase activity 69 25 44
GO:0003677 DNA binding 64 13 51
GO:0005524 ATP binding 58 18 40
GO:0005515 protein binding 47 14 33
GO:0004872 receptor activity 45 9 36
GO:0016491 oxidoreductase activity 45 21 24
GO:0005509 calcium ion binding 44 18 26
GO:0003700 transcription factor activity 42 5 37
GO:0003824 catalytic activity 32 15 17
GO:0004672 protein kinase activity 31 8 23
GO:0004930 G-protein coupled receptor activity 29 5 24
GO:0004674 protein serine/threonine kinase activity 28 8 20
GO:0003723 RNA binding 27 9 18
GO:0005216 ion channel activity 27 7 20
GO:0016301 kinase activity 27 9 18
GO:0003735 Structural constituent of ribosome 26 9 17
GO:0000287 magnesium ion binding 22 5 17
GO:0003779 actin binding 21 12 9








































Fig. 4.2 Verification of selected AEC I-specific genes at mRNA and protein levels. (a, b)
mRNA level: Quantitative real time PCR (qRT-PCR) was performed using an absolute method.
Copy number was obtained from a standard curve constructed from PCR products of each
gene and normalized to 18S rRNA. Fold changes were calculated from copy numbers of AEC I
and AEC II and compared with the DNA microarray data (panel a). Data shown are means ±
SE (n=10 for qRT-PCR, 5 independent cell preparations, each run in duplicate, or n=30 for
array data, 5 biological and 6 technical replications). The mRNA levels of each gene in AEC I
and AEC II were expressed as copy number/106 18S rRNA (panel b, means ± SE, n=10).
Ager: Advanced glycosylation end product-specific receptor, Chrna 10: neuronal nicotinic
acetylcholine receptor subunit alpha 10, Gpxp: plasma glutathione peroxidase precursor, ps20:
wap four-disulfide core domain protein, Apo E: apolipoprotein E, Sparc: secreted acidic
cysteine-rich glycoprotein, crystalline: alpha-b-crystallin, CD9: platelet-cell surface
glycoprotein, Tf: transferrin, and Bsg: basigin. (c-e) Immunolocalization of Apo E, Tf and Tf
receptor (TfR) in rat lung. Double labeling were performed using Apo E antibodies and the
known AEC I marker, T1  antibodies (Panel c), Tf and T1  antibodies (Panel d) or TfR
antibodies and the know AEC II marker, LB180 antibodies (Panel e). The control omitting




Fig. 4.3  Protein quantification of AEC I genes in lung tissue and lavage fluid after
hyperoxia exposure. Rat were exposed to >95% O2 for 48, 60 and 72 hours. Lung tissue
(Panels a & b) and lavage fluid (panels c & d) were collected for measuring protein levels of
AEC I genes by western blot. Panels a and b are representative blots; Panels c & d are
quantitative data determined by densitometry. Data were normalized to -actin and expressed
as a percentage of control (no hyperoxia exposure) from three different animals (means ± SE).
*p<0.05 vs. control; **p<0.01 vs. control.
We selected 10 AEC I-specific genes for further characterization based
on the fold change (log 2 ratio >2), rank (1~500) and their cellular location.
Real time PCR confirmed 9 genes out of 10 (Fig. 4.2a). In general, real time
PCR showed a higher fold change than DNA microarray. The large difference
in expression measured by real-time PCR may resulted from the large data
dynamic range (10~1010 copy-number per gene), selections of oligonucleotide
primers inherited from PCR, low background-to-signal ratio of DNA microarray


































































(housekeeping gene for PCR and LOWESS for microarray). We can not verify
neuronal nicotinic acetylcholine receptor subunit alpha 10 (Chrna10), because
of its low expression. Relative mRNA levels of these ten genes were shown in
Fig. 4.2b. Advanced glycosylation end product-specific receptor (Ager,
NM_05333) had a highest expression in AEC I, followed by secreted acidic
cysteine-rich glycoprotein (Sparc, NM_01265). Platelet-cell surface
glycoprotein (CD9, X76489) and basigin (Bsg, NM_01278) had a middle
expression in AEC I. Other four genes, plasma glutathione peroxidase
precursor (Gpxp, NM_022639), wap four-disulfide core domain protein (ps20,
AF037272), apolipoprotein E (Apo E, S76779) and transferrin (Tf, NM_017055)
had a significant amount of mRNA expression in AEC I and their expression
appeared to be more specific to AEC I. Chrna10 (NM_053336) and
alpha-b-crystallin (M55534) mRNA levels were very low in AEC I. Ager and
Sparc have previously been shown to be cell markers of AEC I (Shirasawa et
al., 2004;Mustafa et al., 2004;Fehrenbach et al., 1998).
 The lung epithelium is directly exposed to the environmental oxidants and
continuously under stress via the generation of reactive oxygen radicals by
inhaled pollutants or during lung inflammation response. AEC II was thought to
be a defender cell in the lung (Fehrenbach, 2001). Our current microarray
analysis identified many of the AEC I genes that appear to play active roles in
lung defense against different stresses. We then directed our attentions to two
of the genes, Apo E and transferrin, and examined whether they participate in
the defense system against oxidative stress. Apo E is a 34 kDa plasma
lipoprotein high-affinity ligand for low density lipoprotein receptors and is
involved in the transport of cholesterol and other lipids (Mahley, 1988). It also
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participates in the nerve injury and regenerative process and protects against
neuronal injury via antioxidant effects (Kitagawa et al., 2002;Lee et al., 2004).
It is also involved in Alzheimer’s disease (Miyata & Smith, 1996). Low density
lipoprotein has been shown to stimulate surfactant synthesis and secretion
(Ryan et al., 2002;Pian & Dobbs, 1997).  Transferrin is another plasma major
iron transport glycoprotein (80 kDa) that transports iron from the plasma to
various cellular localizations (Mateos et al., 1998). The uptake of iron is
mediated by transferrin receptors. Transferrin is the major antioxidant in the
lower respiratory tract through its binding of iron, which exerts toxic effects by
catalyzing highly reactive hydroxyl radicals from superoxide and hydrogen
peroxide in the lung (Pacht & Davis, 1988;Lykens et al., 1992;Gutteridge et al.,
1996;Gerber et al., 1999). It also contributes to anti-infection defense in the
lung. Iron-free transferrin reduces respiratory failure and increases lung
surfactant activity (Hallman et al., 1994)
Apo E and transferrin are primarily synthesized in liver, but also in other
peripheral tissues including lung (Williams et al., 1985;Driscoll & Getz,
1984;Yang et al., 1997). Transferrin levels in bronchoalveolar lavage (BAL)
fluid are higher than that in the plasma (Mateos et al., 1998), indicating its local
synthesis, in addition to coming from the plasma through transudation.
However, local sources of both proteins in the lung are unknown.
Double-labeling of rat lung tissue indicated that Apo E was co-localized with
the known AEC I marker, T1 , suggesting its AEC I localization (Fig. 4.2c). The
control that omits both primary antibodies did not show signals (Fig. 4.2c).
Other controls that omit one of the primary antibodies only show signals in one
“channel” (filter), but not in another (data not shown). In contrast, transferrin
100
was found to be present in both AEC I and AEC II (Fig. 4.2d). The localization
of transferrin in AEC II is likely due to the binding of transferrin secreted by
AEC I to the transferrin receptor on AEC II because transferrin receptors were
only expressed in AEC II, but not AEC I as revealed by double-labeling
transferrin receptor with LB-180, a type II cell marker (Fig. 4.2e). These data
suggest that Apo E and transferrin are synthesized in AEC I, which may
partially account for local sources of these proteins in the alveolar air space.
Induction of antioxidant proteins by oxidative stress is an adaptive and
protective mechanism for cells responding to the stress. We have previously
shown that hyperoxia exposure caused oxidative stress, inflammation, and
acute lung injury (Narasaraju et al., 2003). We reasoned that hyperoxia might
up-regulate Apo E and transferrin expression in the lung.  We therefore
exposed rats to >95% oxygen for different times and determined the protein
levels of these proteins in lung tissues by Western blot. After different-time
point hyperoxia treatment (48 hours, 60 hours, and 72 hours), Apo E and
transferrin protein levels in the lung were increased in an exposure
time-dependent manner (Fig. 4.3 a & b). It is well known that AEC I are more
liable to injury than AEC II. As a result, AEC I markers have been detected in
alveolar fluids after lung injury and used as biochemical markers for acute lung
injury (McElroy et al., 1997). Indeed, Apo E and transferrin proteins were also
increased in BAL fluid (Fig. 3c & d). These increases correspond well with the
severity of lung injury index (Narasaraju et al., 2003). However, the results
should be explained with caution. In addition to the AEC I injury, the increase of
these proteins in alveolar air space also could be due to the increase of the
synthesis and/or the secretion of these proteins by AEC I. In addition to Apo E
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and transferrin, other AEC I proteins including -b-crystallin, CD9, sparc, and
basigin were also increased in both lung tissue and BAL fluid in response to
hyperoxia exposure. (Fig. 4.3 a-d).
Fig. 4.4 Apolipoprotein E and transferrin protect the lung from hyperoxia injury.
Apolipoprotein E (Apo E, 20 µg/100 g BW), or transferrin (Tf, 400 µg/ 100 g BW) were
delivered intratracheally into rat lungs. Since there were no significant differences between
saline and heat-denatured Tf, the data from both groups were combined as vehicle controls.
Rats were exposed to >95% O2 for 60 hours. The plural fluid volume was measured (panel a).
The same volume of lavage fluid was used for the detection of T1  released into alveolar air
space by western blot. The results were quantified by densitometry and expressed as a
percentage of control (no hyperoxia exposure). Data shown are means ± SE from six animals.
Panel b shows a representative western blot. *P<0.01 vs. control; **P<0.05 vs. vehicle group.
Further functional studies were performed to assess whether Apo E and
transferrin can protect alveolar epithelial cells from injury originated from
oxidative stress in an animal model. We used an animal model to study
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whether the delivery of ApoE, transferrin into rat lungs can prevent
hyperoxia-mediated lung injury. Exposure of rats to >95% O2 for 60 hours
resulted in an increase of pleural fluid volume, consistent with previous reports
(Narasaraju et al., 2003). No pleural fluid was observed in the control
unexposed rats. Delivery of Apo E (20 µg/100 g BW) or transferrin (400 µg/100
g BW) to the lungs before O2 exposure significantly reduced amounts of
pleural fluid (Fig. 4.4a). We also used an AEC I marker, T1 , as a biochemical
index of lung injury (McElroy et al., 1997). In the control rats, very little of T1 
protein was detected in BAL fluid. Hyperoxia exposure caused a significant
increase of T1  (Fig. 4.4b and 4.4c).  However, the increase of T1  was
prevented in the Apo E or transferrin-treated rats. The denatured transferrin or
vehicle controls did not provide protection. These data suggest that Apo E and
transferrin can prevent hyperoxia-mediated lung injury.
 In addition to Apo E and transferrin, several AEC I genes identified in this
study may also be involved in lung injury and repair, including Sparc, basigin,
alpha-crystallin B, and CD9. These genes were up-regulated in our
hyperoxia-mediated lung injury model (Fig. 4.3). Sparc (also called
osteonectin, BM40) is a Ca2+-binding stress-related protein and may function
as an extracellular modulator of Ca2+ and other cation-sensitive proteins or
proteases that facilitate cellular proliferation in response to injury (Sage, 1992).
The accelerated wound closure, a condition contributing to enhanced
contractibility, was observed in Sparc-null demise, resulting from its decreased
collagen content (Bradshaw et al., 2002). Sparc accumulation was used as a
marker for stromal repair (Bradshaw et al., 2003). Basigin (also called CD147 or
extracellular matrix metalloproteinase inducer) is a multifunctional
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transmembrane protein involved in inflammation and tumor invasion
(Muramatsu & Miyauchi, 2003). Basigin induces tumor cell invasion by
stimulating the production of matrix metalloproteases from surrounding
fibroblasts (Kanekura et al., 2002). Similarly, basigin released from AEC I may
also trigger the production or release of metalloproteases in AEC I-surrounding
fibroblasts. The released metalloproteases then degrade extracellular proteins
in injured cells and facilitate lung repair. Alpha-crystallin B (heat shock protein
20 or hsp20) is highly expressed in mammal eye lens. Together with hsp27, it
may respond against cell stresses (Horwitz, 2003). CD9,  a member of the
tetraspanin family, is involved in cellular activities such as cell migration,
proliferation, adhesion (Murayama et al., 2004) and the formation and
preservation of various different membrane complexes consisting of several
functional proteins (Kijimoto-Ochiai et al., 2004). Anti-CD9 monoclonal
antibodies inhibited cell proliferation, reduced cell viability and induced
morphological changes specific to apoptosis (Murayama et al., 2004).
This study identified specifically expressed genes in AEC I from the
global gene expression of freshly isolated AEC I and AEC II using 10K rat DNA
microarray. The data suggest that AEC I play active roles in gas exchange,
liquid clearance, lung injury and repair, and lung immune responses. Further
studies of two of the AEC I genes, Apo E and transferrin, revealed their
functions in the cellular defense against oxidative stress. Therefore, the current
studies not only reveal a new function of AEC I cells, cellular defense, but also
change the concept that AEC I is only a barrier for gas exchange. AEC I is a
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Gene Expression Profiles of Rat Type II Pneumocytes During
Hyperoxia Exposure and Early Recovery9,10
5.1 ABSTRACT
Rationale: Alveolar epithelial cell (AEC) injury and repair during hyperoxia
exposure and recovery stages have been investigated for decades, but the
molecular mechanisms of this process are still not completely clear.
Objectives: Identify the potentially important genes during lung injury and
repair. Methods: We studied the gene expression profiling of isolated AEC
type II (AEC II) from control, 48 hours hyperoxia (>95% O2)-exposed (Day 0)
and 1-7 day recovering (Day 1, 3, 5, and 7) rats using DNA microarray
containing 10,000 genes. Measurements and Main Results: Fifty genes
showed significantly differential expression between two or more time points
(p<0.05, fold change>2). These genes can be classified into 8 unique gene
expression patterns. Real-time PCR verified 14 selected genes in three
patterns related to hyperoxia exposure and early recovery. The change in the
9 Contributions of co-authors: Jiwang Chen prepared normal AEC II; Kolliputi Narasaiah
performed Western blot; Manoj Bhaskaran prepared cultured AEC II samples; Tingting Weng
participated in DNA microarray data analysis; Nili Jin participated in real-time PCR, Lin Liu is
the principle investigator.
10 Our microarray dataset has been submitted to GEO and can be accessed by following
steps:
1. Go to webpage http://www.ncbi.nlm.nih.gov/projects/geo/;
2. Go to the bottom of the webpage;
3. Login to GEO; a. user: zhongmingchen; b. password:123456; c. Click  button “Login”;
4. Go to hyperoxia data set; a. GEO accession: GSE2707; b. Click button “GO”
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protein level for one of the selected genes, Dlk1, paralleled that of the mRNA
level. These genes were involved in AEC protection (6), apoptosis (2) and cell
proliferation/differentiation (6). In an in vitro AEC trans-differentiation culture
model, the expression of the cell proliferation/differentiation genes identified
above were consistent with their predicted roles in the trans-differentiation of
AEC. Conclusion: These data indicated that a coordinated mechanism may
control the AEC differentiation during in vivo hyperoxia exposure and recovery
and in vitro AEC culture.
5.2 INTRODUCTION
    Alveoli are the basic gas exchange units of the lung. Their epithelia
consist of alveolar epithelial cells type I (AEC I) and type II (AEC II). AEC I are
squamous and contributes to ~8% of total lung cells. They occupy >95% of
alveolar epithelial surface and function in O2 and CO2 exchange. AEC II are
round and account for ~15% of the lung cells and <5% of the surface space.
AEC II secrete surfactant lipid and proteins and also play roles in xenobiotic
transformation, fluid clearance, and the repair of injured alveolar epithelium.
    Alveoli are constantly exposed to oxygen and environmental stress
(e.g. smoke, pollutant gas) and thus are susceptible to injury. AEC I are more
susceptible to injury due to their large flat shape and inability to perform
mitogenesis. Exposure of animals to hyperoxia, followed by recovery in room
air, is a well-established experimental model for AEC injury and repair (1).
Hyperoxia exposure results in the death of endothelial cells and AEC I,
possibly through necrosis or apoptosis (2). As a result of AEC I injury, these
cells detach leaving behind denuded basement membrane. During the
recovery stages, AEC II proliferate and differentiate to AEC I to replace the
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injured or dead AECs through a cascade of signaling transduction pathways
(3).
    Recently, genomic approaches have been applied for monitoring gene
expression profiles of in vitro cultured AEC in response to glucocorticoid, TNF
and LPS, KGF, and disel exhaust particles treatment (4-7). Microarray analysis
has shown that the 7-day cultured AEC II are different from the freshly isolated
AEC I (8). Using a similar AEC II culture system, we have previously identified
two AEC markers, purinergic receptor P2X7 and gamma-aminobutyric acid
receptor pi subunit using a commercial DNA microarray (9). However, potential
phenotypic changes of AEC during cell culture limit the interpretation of the
results.
    Several groups have used whole mouse lung tissue for gene
expression profiling (10-14). One study has reported changes in gene
expression of lung tissue from mice exposed to hyperoxia for up to 48 hours
(14). However, no recovery phases have been analyzed. The difference in
gene expression among different species has been observed between rats
and mice in response to hypoxia (15). The differential gene expression from
the whole lung tissue reflects the average effect of over 40 different cell types
in the pulmonary system, which makes it difficult to assess changes in a
particular cell type. Also, the average effect may significantly reduce the
sensitivity of DNA microarray analysis. Furthermore, in whole tissue gene
profiling, it is not possible to distinguish between the contributions of lung cells
and infiltrating cells accompanied with inflammation induced by hyperoxia
exposure.
        To eliminate the caveats above, we isolated highly pure AEC II from
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hyperoxia-exposed (48 hours) and recovering (day 0, 1, 3, 5, and 7) rats and
examined their gene expression profiles immediately after isolation using
in-house DNA microarray containing ~6,000 known rat genes and ~4,000
ESTs. Selected genes were verified by real time PCR and western blot. The
global gene expression data systematically revealed the genes responding to
hyperoxia exposure and recovery. Further studies of these genes should shed
light on the mechanisms of alveolar epithelial cell injury and repair, including
AEC proliferation and differentiation.
5.3 MATERIALS AND METHODS
5.3.1 Hyperoxia model
    Hyperoxia model for the present study was used previously in our
laboratory for the investigation of protein nitration (16) and the establishment of
the method for isolating a highly pure AEC II preparation from injured lungs
(17). The Animal Care and Use Committee at the Oklahoma State University
approved the animal protocols used in this study. Male Sprague-Dawley rats (~
250 gram, Charles River Laboratories, Inc., Wilmington, MA) were housed for
1 week before experiments. Rats were exposed to >95% oxygen in a sealed
Plexiglas chamber for 48 hours and then allowed to recover in normal room air
for 1-7 days. The control rats were exposed to room air. The oxygen
concentration was continuously monitored using an oxygen sensor (Vacu-Med,
Ventra, CA) and the flow rate was maintained at 8 L/min using a flow meter.
Rats had free access to food and water. The CO2 in the chamber was removed
by sodalime.
5.3.2 AEC II isolation
    AEC II were isolated from control, hyperoxia-exposed and recovering
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rats according to our recently improved method (Chen et al., 2004b). The
purities of AEC II preparations were in the range of 93-97% as determined by
the modified Papanicolaou staining. The yields were 20-40 x 106 per rat with a
peak on Day 1 (40.00 ± 4.08 x 106). The viability of these cells was over 92%.
Four independent AEC II preparations from each time point [control (A2), 48
hours-exposed (D0), and recovering for 1, 3, 5, and 7 days (D1, D3, D5, and
D7)], were used for RNA isolation and microarray hybridization.
5.3.3 RNA isolation
    Total RNA was extracted using TRI reagents (Molecular Research
Center, Cincinnati, OH). RNA quality and quantity was assessed with agarose
gel electrophoresis and A280/A260 ratio with spectrophotometer (NanoDrop
Technologies, Inc, Rockland, DE). The A280/A260 ratios for all RNA preparations
were >1.8.
5.3.4 Microarray Printing
    The DNA microarray slides used in this study were printed in-house
on glass slides with 50-mer aminated oligonucleotides, Pan Rat 10K
Oligonucleotide Set (MWG Biotech Inc., High Point, NC). It contained 6,221
known rat genes, 3,594 rat ESTs, and 169 Arabidopsis negative controls. The
oliogonucleotides were suspended in 3x SSC at 25 µM and printed on epoxy
coated slides (CEL Associates, Pearland, Texas) with an OmniGrid 100
arrayer (GeneMachine, San Carlos, CA) per manufacturer’s instruction. Each
oligonucleotide was spotted in triplicate on three identical 18 x 18 mm blocks:
A, B, and C. The spot-spot distance was 180 µm and the space between
blocks was 4 mm. After printing, the slides were incubated in 65% humidity
overnight at room temperature. The slides were then dried and stored at room
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temperature. Printing spots were uniform as assessed by staining slides with
SYTO 61 red fluorescent nucleic acid stain dye.
5.3.5 Microarray hybridization
    The 2-step microarray hybridization was carried out with the 3DNA 50
Expression kit (Genisphere Inc., Hatfield, PA). Prior to hybridization, the slides
were washed with 0.2% SDS once and with deionized water for 4 times, and
then dried by centrifugation. The 3 blocks on a slide were separated by two 2 x
25 x 1 mm thermostatic transparent tape strips to allow the hybridizations of 6
independent dual-color labeled biological samples. The strips were removed
after hybridization for washing and scanning slides. Total RNA from each AEC
II sample (A2, D0, D1, D3, D5 and D7) was split into two aliquots; 5 µg each for
reverse-transcription with Cy3- or Alexa 647-specific primers. cDNAs were
purified with Microcom YM-30 columns (Millipore, Billerica, MA), adjusted to
0.5-0.6 µg/µl, and mixed with 2x formamide hybridization buffer (50%
formamide, 6x SSC, and 0.2% SDS) in an equal volume. The DNA microarray
slides were hybridized with paired cDNAs at 42oC for 48 hours. After being
washed, the slides were re-hybridized with Cy3- and Alexa 647-specific
capture reagents at 42oC for 2 hours. After the 2-step hybridizations, each of
the hybridized slides was scanned twice with a laser confocal scanner,
ScanArray Express (PerkinElmer Life and Analytical Sciences. Boston, MA),
one for the spot quantification with 90% laser power and 70~80% PMT so that
about 5% spots were saturated, and another one for the spot alignment with
90% laser power and 95% PMT.
5.3.6 Microarray data analysis
    Raw data were extracted from the DNA microarray hybridization
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images with GenePix Pro 4 (Axon Instruments, Inc. Union City, CA). Spot
image visualization, spot quality evaluation, data normalization, and one-way
ANOVA for the identification of the differentially expressed genes were
performed as previously described using the software package RealSpot
developed in our laboratory (18). The data set from RealSpot contained
LOWESS normalized log2 ratios (D0/A2, D1/D0, D3/D1, D5/D3, D7/D5 and
A2/D7), globally normalized fluorescence intensity, quality index (QI), and
one-way ANOVA p-value (p<0.05, for all the statistical analyses in the present
study). QI was calculated based on signal intensity and signal-to-background
ratio (18). A QI of 0, 1, 2, 3, 4, and 5 represents negative, weak, middle, strong,
saturated and bad spots, respectively.
    The differentially expressed genes among different time points during
hyperoxia exposure and recovery were identified based on both fluorescence
intensities and normalized log2 ratios. First, we filtered low quality spots with a
mean QI of 1.0 (negative spot). Second, a statistical test was performed on
fluorescence intensities using one-way ANOVA. The genes with a p-value of
>0.05 (no significant changes between any time points) were excluded. Third,
the differentially expressed genes between any two adjacent time points were
identified by t-test using log2 ratios.  For instance, a gene was differentially
expressed between day 0 and 1, if log2 (D1/D0) was significantly different from
0. Fourth, the remaining genes were further filtered by a fold change of >2 to
reduce the false-positive and to facilitate real-time PCR verification. The
choice of 2-fold change as a cut-off value was arbitrary.
    Finally, the genes from step 4 were classified into different gene
expression patterns using a trajectory clustering-like algorithm (19), in which
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the gene expression directions, up-, down- and flat-regulation, were used to
cluster in iterative steps. The mean log2 ratios of any two time points were
replaced, based on the above p-values (p<0.05) and log2 ratios, by a symbol
“^” (log2 ratio>1, up-regulation), “v” (log2 ratio<-1, down-regulation), or “~” (no
significant change). By grouping 6 symbols of log2 ratios (D0/A2, D1/D0,
D3/D1, D5/D3, D7/D5 and A2/D7), the differentially expressed genes were
classified into several unique gene expression patterns. For instance, a pattern,
“~^~~~~”, means D0=A2, D1>D0, D3=D1, D5=D3, D7=D5 and A2=D7. In
other words, the genes in this pattern were expressed significantly higher on
day1 than on day 0.
    The functional categories of each pattern were based on gene
ontology annotation from Rat Genome Database gene association file (RGD,




     The validation of selected targeted genes with QuantiTect SYBR
Green PCR Kit (Qiagen Inc., Valencia, CA) was performed as previously
described (Chen, Jin, Narasaraju, Chen, McFarland, Scott, & Liu, 2004d).
Total RNA (1 µg each) were reverse-transcribed into cDNAs with 0.2 g/ l
dT17, 0.3 g/ l random hexamer primer, and 200 U MMLV reverse
transcriptase (Invitrogen Inc., Carlsbad, CA). The real-time PCR thermal
conditions for all genes were 95oC for 15 min, followed by 40 cycles each at
95oC for 30 sec, 60oC for 30 sec, 72oC for 30 sec and 77oC for 35 sec (signal
collection temperature). The primer pairs are listed in Table 5.1. The relative
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real-time PCR quantification was based on the delta delta Ct method (20). The
endogenous reference gene was beta actin (actb), which was not differentially
expressed between any time points during hyperoxia exposure and recovery.
One-way ANOVA tests were performed to compare the mRNA levels
statistically among the samples from the different time points.
Table 5.1: Real-time PCR primers
Gene name Sequence (forward and reverse)
AAG GAG TGC CGC TGA AAC TGTHeat shock 10 kd protein 1 (hspe 1) GCT GAA TCT CTC CAC CCT TTC C
TCC AGA CCC TTG CTA CCA ATGCcaat binding transcription factor cbf subunit
c (nfyc) GCT GGT TGG CTG ACT GAA TAA A
CCC GAG AAA AGG AAC TGG TGA AMesenchyme homeobox 2 (meox2) TAT CGC GAC TGT CGT CAT TTG C
GGA GGA CAC GCT GAA ACT CTC AStearyl-coa desaturase (scd1) GGA AAA CCT CTG CCA TGC ATC T
GCA GAC TCT CGA CCT CAT CAC ATestis-specific farnesyl pyrophosphate
synthetase (fdps) CCC ATC AAT TCC AGC CAT G
GCA ACT GCC TGT GCT TAA TCG TResistin-like molecule alpha (retnla) TGC GCA TGA GTC AGA TTT CCA
AGA ATC ACC GCA CAC CTG GTTThiolase aa 1-397 (acaa2) AAT CCC TTC AGG CTG TGT TCT G
GTC TTC GCG GTT AGC TCC ATAFerritin light chain subunit (ftl1) CAC GTC ATC CCG ATC AAA AAA G
TGA AGA ATG GCA CAT CCT TCG APreprocathepsin d (ctsd) TGG CTT CCC CAA AGA TCT GTT
TGC ACC TGC TCG GAC AAA TMetallothionein 3 (mt3) CCC TCT TCG CCT TTG CAA A
CAG GAT TTC TCT GCC TCT TCC AVimentin (vim) CCT GTC CGT CTC TGG TTT CAA C
CCC AGG CCC TTC TAC ATT ATC GDelta-like homolog drosophila (dlk1) GCA GCT TGT CAC ACA GCA ACA C
CTC AGA GCA ACA GTG CCA AGG AO-acetyltransferase milk fat glolbule
membrane protein (mfge8) TCC ACT GCA CAC CAT CAT CAC
CCC TGG CAA AAT CGG CTA CTARgc32 protein TTG AAT ATG GTG CAG GCA GGT A
TTC AGA GCT TAC CAC CGA ATG GUrinary plasminogen activator receptor 2
(plaur) GCC TCC AAG CAC TGA TTC ATT G
CAA ACC CCG ATT TCC TTT GAGCytosolic peroxisome proliferators -induced
acyl-coa thioesterase (bach) AGT GTG CTC TGG TGT CCA CGA T
CGC TTC CTA GGT AAG CGC TCT AMetallothionein 2a (mt2a) TCG CAA CAT ATT CCC CAC TCA T
CCC TGG TCA ACT CCG TTA ATT CTBone morphogenetic protein 4 (bmp4) CAC CTT GTC GTA CTC GTC CAG AT
ACC GTG AAA AGA TGA CCC AGA TBeta actin (actb) CAG TGG TAC GAC CAG AGG CAT A
TAA CTA AGT GCT GCC CTC TGASurfactant protein A (SP-A) ACT AGG CTT TCC CAG AAA TCC
AGC CCA CCG GAT TAC TCG ACSurfactant protein C (SP-C) AGG ACT ACC ACC ACA ACC ACG
GGC AGG TGC TAG AAA CTG GTTT1 alpha (T1a) GCC GTT GAC GAA CCA AGA AC
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5.3.8 Western blot
    Total protein was obtained from control, hyperoxia-exposed, and
recovering AEC II after the TRI reagent extraction (see RNA isolation)
according to the manufacturer’s instruction. SDS-PAGE and Western blot were
performed as previously described (16). The dilutions of antibodies were: goat
polyclonal anti-dlk1 (Abcam, Cambridge, MA), 1:100; mouse monoclonal
anti-beta actin (Sigma, St. Louis, MO), 1:1000; horseradish peroxidase
conjugated (HRP)- mouse anti-goat (Abcam),1:1000; and HPR-rabbit
anti-mouse (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA),
1:1000.
5.3.9 Cell culture
    An in vitro cell culture system for the trans-differentiation of AEC II to
AEC I-like cells was used to assess the expression of the identified genes (9).
Briefly, the freshly isolated AEC II were re-suspended in the minimal essential
medium with 1% fetal bovine serum. AEC II were cultured in 37oC and 5% CO2
in the plastic dishes for 1, 3, 5 and 7 days. At each time point, total RNA was
extracted as described above. T1  (an AEC I marker), surfactant proteins A
and C (SP-A and SP-C, AEC II markers), and selected genes from the DNA
microarray data were monitored by real-time RT-PCR.
5.4  RESULTS
5.4.1 Hyperoxia model
We have previously observed that the exposure of rats to >95%
oxygen leads to lung injury and the severity of injury depends on the duration
of the exposure time (16). When rats were exposed to >95% for 48 hours,
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alveolar epithelium was disrupted but regained its normal structure during the
7 days of recovery. Coinciding with the alveolar injury, rat body weight
significantly decreased during the hyperoxia exposure (control, 252.17 ± 3.98
gram, hyperoxia, 240.08 ± 6.22 gram) and increased during the recovery for
1-7 days (Day 1, 257.00 ± 0.43 gram, Day 3, 253.50 ± 1.92 gram, Day 5,
277.50 ± 1.64 gram and Day 7, 286.00 ± 1.28 gram). To identify the genes in
AEC II, which are important for hyperoxia response and early recovery, we
performed DNA microarray on the isolated AEC II from hyperoxic and
recovering rats. AEC II were isolated from control (A2), 48-hour hyperoxia
exposed (D0), and recovering for 1, 3, 5, and 7 days (D1, D3, D5, and D7) rats.
Even though there were inflammatory cells flooding into the injured lungs, we
were able to obtain >93% pure of AEC II for all of the cell preparations using
our recently improved method, which removes inflammatory cells such as
macrophages and lymphocytes by negative immunomagnetic selection (17).
5.4.2 Differentially expressed genes
    We used 4 independent preparations of AEC II in the current study,
each with 6 time points (A2, D0, D1, D3, D5, and D7). The samples at 6 time
points for each biological replication were labeled with green or red dyes and
simultaneously hybridized to 3 different blocks in a green-red pair on one
single slide (Fig. 5.1A). cDNA samples were paired in a loop-style, each with
dye-flip to compensate the dye-specific bias (Fig. 5.1B). After hybridization
image quantification and data normalization, we sequentially filtered 2,218
genes with a low quality spot (mean QI <1.0, negative spot), 5,405 genes with
no significant changes based on fluorescence intensities (one-way ANOVA),
2,005 genes with no significant changes based on log2 ratios (t-test), and 322
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genes with a fold change of <2. (See Materials and Methods for detail on data
analysis). The final 50 genes were listed in supplementary Table S1 (66).
Twenty-eight genes changed between A2 and D0, or D0 and D1, and 20 genes
between D5 and D7, or D7 and A2 (Fig. 5.1C).
Table 5.2 Gene ontology of the significantly changed genes in AEC II



























Cancer 1  1
Cell cycle 5  2  1  1   1
Cell differentiation 2    1   1
Cell proliferation 1  1
Chaperone 1      1
Histone 2  2
Hormone 1   1
Intermediate
Filament
3 1   1   1
Ion binding 1        1
Ion channel 2  1     1
Lamin 1       1
Metabolism 6  1 1 1 1 1 1
mRNA export 1       1
Peptidase 1     1
Phagocytosis 1   1
Phosphorylation 3  1    2
Telomerase 1       1
Transcription 6 1 1 1  1 1  1
Unclear 11 1 1 2 2 2 1 1 1
Total 50 9 7 6 6 7 7 6 2
The significantly changed genes were identified by two statistical tests (one-way ANVOA and
paired t-test) and using a fold change cut-off value of 2. The gene expression pattern was
classified based on the significance of log2 ratios. Symbol meanings, ^, up-regulation (p<0.05,
log2 ratio>1.0), v, down-regulation (p<0.05, log2 ratio<-1.0), ~, not significantly changed. The
symbols were arranged in order of D0/A2, D1/D0, D3/D1, D5/D3, D7/D5 and A2/D7.
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Fig. 5.1 DNA microarray analysis of alveolar epithelial type II cells during hyperoxia
exposure and recovery.  (A) DNA microarray slide layout. The array has three identical
blocks, A, B, and C. Each contains ~ 6,000 known genes and ~ 4,000 ESTs. The three blocks
are separated by thermal plastic tapes. Three paired Cy3-(green) and Alexa 647 (red)-labeled
cDNA samples were hybridized onto the three blocks.  (B) Loop hybridization design. Six
AEC II samples were isolated from normal control (A2), 48 hours-hyperoxia exposed (D0), and
subsequent recovery in room air for 1, 3, 5, and 7 days (D1, D3, D5, and D7). The samples
were paired in a loop style, each with dye-flipping, A2-D0, D0-D1, D1-D3, D3-D5, D5-D7, and
D7-A2. There were 4 biological replications (4 independent cell preparations). (C) Differentially
expressed genes. Two statistical analyses, a one-way ANVOA and a paired t-test, identified 50
genes that had a fold change of more than 2 for at least two time points. For each ratio, the
genes that were >2 (increase) or <2 (decrease) were counted. The percentage of each ratio is
the sum of the increase and the decrease count divided by total gene count.
5.4.3 Gene expression patterns during hyperoxia exposure and
recovery
    In order to elucidate the relationship between gene expression
changes and the time points of alveolar injury and repair, the 50 identified
genes were classified into 7 unique gene expression patterns, each with 6 or
more genes (Fig. 5.2A~F) and 2 orphan genes (Fig. 5.2O). Gene expression
patterns, symbols, and meanings are listed in Table 5.2. In pattern B (~^~~~~),
C (~v~~~~), E (~~~~v~), and G (~~~~~^), genes were up- or down-regulated





recovery after hyperoxia exposure since each gene in these two patterns was
expressed significantly different between day 0 and day 1. Similarly, patterns E
and G may play a role in the later stages of recovery. This is evident because
of the difference in gene expression between day 5 and 7, or day 7 and normal
control.  The other patterns, A (v~~~~^), D (^v~~~~), and F (~~~~^^), showed
more complex gene regulations among three or more conditions, and thus may
participate in multiple stages of lung injury and repair induced by hyperoxia
exposure and recovery. The genes in pattern A were down-regulated during
hyperoxia exposure and up-regulated in late recovery stage. Pattern D showed
an expression peak on day 1, implying a role in the early recovery. In pattern F,
the genes were up-regulated in the late recovery (day 5 to day 7).
    The gene functional categories (ontology) of 50 identified genes are listed
in Table 5.2. Notably 11 genes are not functionally characterized. There were
several genes related to cell growth and differentiation (cell cycle,
differentiation and proliferation, and telomerase), indicating that there was a
active alveolar repair during hyperoxia exposure and recovery.
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Fig. 5.2  Gene expression patterns in alveolar epithelial type II cells during
hyperoxia exposure and recovery. Left panel ( ): log2 ratio changes between time points.
Fifty genes, identified by statistical tests and a 2-fold change cut-off value were classified into 7
groups (A-G) and one orphan group (O, 2 genes) based on significant changes at two or more
time points. The Y-axis is the log2 ratio. The values shown are means ± S.D. of all genes in
each pattern (gene number: A, 9; B, 7; C, 6; D, 6; E, 7; F, 7; G, 6; and O, 2). A2, normal
alveolar type II cells (AEC II), D0-D7: AEC II from 48 hours hyperoxia exposure and
subsequent recovery for 0-7 days. *P<0.05, log2 ratio of each gene in each pattern vs 0. The
expression pattern symbol: ~, no significant change; ,̂ P<0.05, log2 ratio >2, and v, P<0.05,
log2 ratio <0. Right panel ): diagram of relative mRNA abundance among time points.
Y-axes are relative mRNA abundance, and x-axes are time points of hyperoxia exposure and
recovery, Meanings of patterns A-O are identical to left panel. * p<0.05: the mRNA D0 or D7 vs




Fig. 5.3 Comparisons of log2 ratios from DNA
microarray and real-time PCR. The genes
from pattern B (Panel A), Pattern C (Panel B)
and Pattern D (Panel C) were selected for
verification by quantitative real time PCR (qPCR).
The microarray data was LOWESS normalized
and real time PCR data was normalized to
β-actin. Error bars represent standard errors. All
of the log2 ratios were significantly different from
0 (p<0.05). There were 4 biological replications
for both microarray and real time PCR analyses.
A2: normal alveolar type II cells (AEC II); D0 and
D1; 48 hours hyperoxia exposure and recovery
for 0 and 1 day.
5.4.4 Data validation
Next, we selected some genes for verification with real-time PCR.
Because of our research interests in lung injury and repair, in particular, cell
proliferation and differentiation, we focused on the genes that change during
the early recovery stages between day 0 and 1 (Patterns B, C, and D).
Consequently, 19 genes in patterns B, C and D were chosen. Real-time PCR
data indicated that 14 genes were consistent with DNA microarray data (Fig.
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5.3). The known functions of the 14 genes were listed in Table 5.3. In most
cases, the real-time PCR resulted in a higher fold change than microarray. This
was probably because the real time PCR calculations were based on the delta
delta Ct method and also because of the differences between solid-state
(microarray) and solution hybridization (PCR) (20). Both microarray and
real-time PCR revealed that 5 genes (retnla, bmp4, fdps, hspe1, and meox2)
were expressed significantly higher on day 1 than day 0 in pattern B (Fig.
5.3A). In patterns C and D, 9 genes (dlk1, acaa2, mt3, ftl1, bach, plaur, rgc32,
mfge 8 and mt2a) were consistently expressed higher on day 0 than day 1 in
both real-time PCR and microarray assays (Fig. 5.3B & C).
    The five genes that did not show consistent results may be due to low
mRNA abundance, poor amplification (featured by high Ct), and high variation
among samples or difference in data normalization (LOWESS vs
housekeeping gene). Scd1 was not significantly changed from day 0 to day 1
by real-time RT-PCR, but microarray assay indicated that scd1 was expressed
significantly higher on day 1 than on day 0 (log2 ratio of D1/D0=1.59 ± 0.32).
Nfyc and smad5 showed the opposite log2 ratio of D1/D0 from microarray
(1.1±0.28 and -1.6±0.44) and real-time PCR (-3.4±0.95 and 1.66±0.38),
respectively. Vim and ctsd showed consistent log2 ratios of D1/D0 by
microarray (-1.2±0.19 and -1.0±0.18) and real-time PCR (-2.1±0.66 and
-4.0±1.32), but inconsistent log 2 ratios of A2/D0 by microarray (1.73±0.56 and
0.69±0.12) and real time PCR (-3.7±0.85 and -1.4±0.38).
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Table 5.3: The known functions of 14 verified genes
Genbank Gene name Function
Pattern B (~^~~~~): Day1 > Day 0  .
NM_053333 Resistin-like molecule alpha
(retnla)
May act as a hormone; lung inflammation
NM_012827 Bone morphogenetic protein 4
(bmp4)




Isoprene biosynthesis; cell membrane
synthesis
NM_012966 Heat shock 10 kd protein 1
(hspe1)
Stress-induced mitochondrial matrix protein
and molecular chaperone
NM_017149 Mesenchyme homeobox 2
(meox2)
Homeobox gene; may have a regulatory
function in the G0-to-G1 transition of the cell
cycle in vascular smooth muscle cells




Involved in fatty acyl-CoA oxidation
NM_017350 Urinary plasminogen activator
receptor 2 (plaur)
Involved in plasminogen activation
NM_054008 Rgc32 protein (rgc32) Increased expression is detected in
oligodendrocytes in response to
complement activation; may play a role in
cell cycle activation
NM_012811 O-acetyltransferase milk fat
glolbule membrane protein
(mfge8)
Involved in the o-acetylation of gd3
ganglioside sialic acid
M11794 metallothionein 2a (mt2a) Neuroprotective proteins, may provide a
cellular defense strategy in response to DNA
damage
Pattern D (^v~~~~): Day 0 > AEC II and Day 1
NM_053744 Delta-like homolog drosophila
(dlk1)
Involved in maintaining the undifferentiated
status of the preadipocyte
X05341 Thiolase aa 1-397 (acca2) Mitochondrial matrix protein with
acetyl-coenzyme A acyltransferase 2 activity
NM_053968 Metallothionein 3 (mt3) May inhibit cell growth in nervous system
NM_022500 Ferritin light chain subunit 1
(ftl1)
Iron storage
* The function descriptions were from GeneRIF
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=Graphics).
    Based on the availability of suitable antibodies, we further confirmed
dlk1 at the protein level in hyperoxic and recovering AEC II. Western Blot was
performed on A2, D0 and D1. Data were quantified by densitometry and
normalized to β actin. The expression of dlk1 at the protein level was
significantly higher on day 0 than on A2 or D1, consistent with the change in
mRNA expression (Fig. 5.4)
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Fig. 5.4 Dlk1 protein
expression in hyperoxic and
recovering AEC II. The AEC
IIs were from control (A2), 48
hours hyperoxia-exposed (D0)
and recovering for 1 day (D1)
rats. Dlk1 protein level was
detected by western blot using
anti-Dlk1 antibodies, quantified by densitometry, and normalized to -actin (Actb). The results
were expressed as a percentage of control (A2). Data shown are means ± SE (n=3).
Fig. 5.5 Expression patterns of 6 cell
differentiation-related genes in in vitro AEC culture
model. Freshly isolated alveolar type II cells (A2) were
cultured on plastic dishes for 1, 3, 5, and 7 days (D1,
D3, D5, and D7). The mRNA level was measured by
quantitative real-time PCR. The results were
expressed as log2 ratios between two time points. The
values are mean log2 ratio, and the error bars are the
standard errors. *P<0.05 vs 0; #P<0.05 vs. 0. Data
were from 4 Independent cell preparations, each
measured in duplicate. (A) SP-A, SP-C and T1 ; (B)
retnla and dlk1; (C) rgc32, bmp4, mexo2 and fdps.
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5.4.5  Gene expression during in vitro trans-differentiation of AEC
    It is well known that AEC II gradually trans-differentiate to AEC I-like
cells when cultured on plastic dishes in vitro (21). Using this model, we further
studied 6 genes that may be involved in cell proliferation and differentiation.
AEC II (A2) isolated from normal rats was cultured with 1% FBS for 1, 3, 5 and
7 days (D1, D3, D5 and D7). The morphology of AEC II (round) gradually
changed to AEC I-like cells (flat) (data not shown). The mRNA of T1 , an AEC I
marker, was significantly higher on day 3 than on day 1 during in vitro culture
(Fig. 5.5A). In contrast, SP-A and SP-C (AEC II markers) were markedly
down-regulated in freshly isolated AEC II compared to day 1 and day 3,
indicating the phenotypic change of AEC II to AEC I-like cells at day 3. Dlk1
and retnla decreased significantly in freshly isolated AEC II after 1 or 3 day
culture (Fig. 5.5B). Rgc-32, bmp4, meox2 and fdps were expressed lower on
day 1 than freshly isolated AEC II. However, the expression of these genes
increased on day 5 in comparison to day 3 (Fig. 5.5C). A simplified gene
expression scheme of the 6 genes was drawn based on the results from
models of hyperoxia and cell culture (Fig. 5.6). Five out of the 6 genes were
down-regulated during cell culture from AEC II to day 1. Among other genes
identified above, mt2a has a change similar to dlk1 and retnla. Plaur, ftl1 and
bach did not exhibit any significant changes at any time points. Mfg8 and
acaa2 were expressed significantly higher on day 3 than on day 1. Hspe1 and
mt3 were expressed lower on day 3 than on day 1 (data not shown).
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Fig. 5.6 Gene expression
diagrams of 6 cell differentiation-
related genes in the models of in
hyperoxia (left panel, from
microarray data) and AEC culture
(right panel, from real-time PCR).
Y-axes are relative mRNA
abundance, and x-axes are time
points of hyperoxia exposure and
recovery, or cell culture.* p<0.05, A2
vs. D7, # p<0.05, between two
adjacent time points (the respective
line between them has a -45 or
45-degree slope).
5.5  DISCUSSION
The gene expression profiles of freshly isolated AEC II from normal,
hyperoxic, and recovering rats were investigated using DNA microarray. We
identified and verified 14 genes, which changed significantly during hyperoxia
exposure or early recovery stages. These genes may be involved in AEC
protection, apoptosis, and cell proliferation and differentiation. The mRNA
expression of the six cell differentiation-related genes was determined in an in
vitro trans-differentiation culture model of AEC. Common events of AEC II
proliferation and differentiation between the models of hyperoxia exposure and
cell culture were proposed (Fig. 5.7). The information from this study may
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serve as a starting point for further investigation of alveolar injury and repair.
Fig. 5.7 Functional scheme of the 6 genes during AEC II proliferation and differentiation.
The middle double line oval represents an AEC II during proliferation and differentiation, and
the other two smaller double line ovals are adjacent cells in vivo or in vitro. The gray circles
inside cells are nuclei. Round text boxes represent the proteins. The 6 genes are highlighted.
Genes in cylinders are plasma membrane receptors. Highlighted arrows indicate
protein-protein interactions related to 6 genes, and gray arrows indicate other protein-protein
interactions. Signaling pathways or interactions are showed in gray ovals. Main abbreviations:




























Hyperoxia injury and repair is a complex model composed of various
biological processes, including hyperoxia-mediated lung injury during the
exposure and subsequent lung tissue repair (cell proliferation, differentiation
and apoptosis) during the recovery. Since these events are sequential, we
used a loop design to compare adjacent time points in order to better probe
gene expression in a particular event such as cell proliferation and
differentiation. This method has several advantages over a reference design.
In a reference design, each time point needs to hybridize to a common
reference (i.e. control, or D0, or pooled samples). Since any two time points
must be indirectly compared through a common reference, the reference
design results in accumulated errors from two hybridizations (i.e. each time
point vs reference). Also the reference design has a lower dynamic range. In
the case of pooled samples as a reference, assuming that the expression level
of a gene in A2 is 100 and that of any of other 5 samples (D0, D1, D3, D5, and
D7) is 1, the ratio of A2 vs reference is 100/(105/6) = 5.7. This is much lower
than the ratio of A2 vs. another sample (100/1 = 100) in the loop design.
     In the current study, there were two statistical tests based on
fluorescence intensities and log2 ratios, which eliminated type I (false positive)
and type II (false negative) errors resulting from the multiple comparisons of
thousands of genes. For instance, there were about 389 false positive genes
(5% of 7,782) after one-way ANOVA of fluorescence intensities. The false
positive genes were reduced to about 19 (5% of 389) after t-test of log2 ratios.
Thus, the two-step tests greatly improved the reliability of the genes identified
from DNA microarray data. With an alternative one-step approach, Bonferroni
correction, no significantly differential gene expression was detected because
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of the p-value adjustment to 6.43 x 10-6 (=0.05/7782). This correction insured
that the global type I error was 0.05, but increased the type II error and
excluded many truly differentially expressed genes.
AEC protection  Functionally, 6 genes may be involved in AEC protection
during hyperoxia exposure and recovery, including thiolase aa 1-397 (acaa2),
cytosolic peroxisome proliferator-induced acyl-coa thioesterase (bach),
metallothionein 2a and 3 (mt2a and mt3), plasminogen activator receptor 2
(plaur), and resistin-like molecule alpha (retnla). These genes participate in
fatty acid oxidation, growth inhibition, host defense, and lung inflammation.
Acaa2 is a mitochondrial acetyl-CoA acyltransferase (22). Bach is a cytosolic
acyl-CoA thioesterase and its activity is induced by peroxisome proliferators
(23). In context of the rat hyperoxia model, these two genes in the fatty acid
beta oxidation pathway may respond to a high concentration of oxygen by
consuming oxygen, since both genes showed a higher expression during the
hyperoxia exposure. They may have a protective effect on AEC during the
exposure stage. Plaur regulates cell-surface plasminogen activation in normal
and pathological processes and is critical for pericellular proteolysis. It plays a
role in lymphocyte recruitment to the lung (24).  It also has an anti-bacterial
effect in the lungs of plaur -/- mice (25). Its augmented expression during
hyperoxia exposure indicates its potential role in the protection of AEC against
alveolar injury. TNF-  up-regulates the plaur expression in the AEC II cell line,
A549. These results support that plaur may be involved in inflammatory
response by recruiting the immune cells to injured AEC and activating the
subsequent cellular immune response (4). Two highly homological
metallothionein genes, mt2a and mt3 show changes during hyperoxia
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exposure and early recovery. This is consistent with a previous study, in which
metallothionein increases 7 folds in the whole mice lung tissue after 48 hr
hyperoxia exposure (14). Metallothioneins are 6-7 kDa metal-binding
antioxidant proteins. They are induced by oxidative stress (14; 26; 27) and
protect the lung from acute injury (28). Mt3 also inhibits the neuron growth in
the neonatal rats (29). Retnla, also known as found in inflammatory zone 1,
FIZZ1, is a ~ 9 kDa cysteine-rich secreted protein and has been identified in
the bronchoalveolar lavage fluid of the allergen-induced inflamed lungs (30).
Its expression is markedly increased in the bronchial epithelial cells and
alveolar epithelial type II cells in inflamed lungs, likely by cytokines, IL-4 and
IL-13 via STAT6 and c/EBP (31).
AEC apoptosis  O-acetyltransferase milk fat globule membrane protein
(mfge8) and heat shock 10 kd protein 1 (hspe1) may regulate AEC apoptosis
during hyperoxia exposure and subsequent recovery phases. A prolonged
hyperoxia exposure is known to damage mitochondria, resulting in AEC
apoptosis. Mfge8 is a secreted glycoprotein that bridges apoptotic cells to
phagocytes for their removal. It has two EGF-like domains, a mucin-like
domain, two C-domains for phospholipid binding and a RGD motif for v 3
integrin binding (32). Mfge8 binds to apoptotic cells via phosphatidylserine and
increases the engulfment of apoptotic cells by phagocytes through v 3
integrin (33; 34). Hspe1 (also known as hsp10) is a molecular chaperone and
plays an anti-apoptotic role by the formation of a complex composed of
pro-caspase-3, hsp10 and hsp60 (35).  It also inhibits the ubiquitination of the
Bcl-xl protein (36). Our current DNA microarray data shows that only a few
apoptosis-related genes are significantly changed during hyperoxia exposure
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and recovery stages. For instance, a medium to high mRNA abundance of
bcl-xl and bax in normal, hyperoxic and recovery AEC II are observed, but no
significant changes are evident (data not shown). On the other hand, fas is
expressed significantly higher in normal AEC II than in hyperoxic or recovering
AEC II (data not shown). A similar result from the microarray analysis of whole
mouse lung tissue has been obtained except that Bcl-xl is increased at 24 hr of
hyperoxia exposure (14).  Clearly, apoptosis is required to resolve the
increased number of AEC II during the recovery phase in order to repair
alveolar epithelial injury.  In addition to mRNA changes, apoptosis-related
proteins in AEC may also be regulated at protein translational or
post-translational modification levels.
Cell proliferation and differentiation Six genes, delta-like homolog
drosophila (dlk1), bone morphogenetic protein 4 (bmp4), mesenchyme
homeobox 2 (meox2), testis-specific farnesyl pyrophosphate synthetase (fdps),
response gene to complement (rgc-32), and resistin like kinase alpha (retnla)
were relevant to cell proliferation and differentiation. Their functional roles
were summarized in Fig. 5.7. The 6 genes except retnla may modulate MAPK
signaling pathway during AEC II proliferation and differentiation. Bmp4 protein
may regulate AEC II proliferation and differentiation through TGF  signaling
pathway.
Dlk1 (also known as preadipocyte factor 1, Pref-1) was a member of the
notch/delta/serrate family and contains 6 EGF-like repeats and a
transmembrane domain. It functioned in cell fate determination and cell
differentiation in various tissues and cells. For instance, Dlk1 inhibited the
differentiation of adipocytes (38), bone marrow stromal cells (39), human
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hematopoietic cells (40), adrenal gland cells (41), and neuroendocrine cells
(42). Dlk1 modulated IGF-1 receptor and regulated ERK/MAPK signaling
pathway during cell differentiation (43).  Dlk1 may play dual roles during AEC
II proliferation and differentiation. First, it may interact with notch receptors on
the cyctoplasma membrane of other cells (e.g. AEC I, AEC II or macrophage in
alveoli, or AEC II cultured in plastic dishes), and regulate cell differentiation
through the notch signaling pathway (44). Second, Dlk1 or the notch-dlk1
complex may modulate IGF1 receptor, which in turn affects cell proliferation
induced by IGF-ERK-MAPK pathway. Dlk1 was up-regulated during hyperoxia
exposure (A2 to D0, Fig. 5.6), which may activate a portion of AEC II to cell
proliferation and differentiation status. No up-regulation of dlk1 expression
during AEC II culture was observed. The Dlk1 showed down-regulation during
hyperoxia early recovery stage (day 0 to day 1) and cell culture (day 1 to day
3). Dlk1 repression may decrease the proliferation effect through IGF1R
modulation, and shift AEC II to differentiation. The adjacent cells around AEC II
may induce cell differentiation in vivo or trans-differentiation in vitro. In
hyperoxia model, AEC, macrophage and endothelial cells may affect AEC II
differentiation through Notch-Dlk1 interaction to regenerate normal AEC I and
AEC II for alveoli repair. On the other hand, the relatively uniform AEC II in
plastic dishes induced AEC I-like cells. These results indicated that cell-cell
interactions may play a role in the formation of normal AEC I and AEC II during
cell differentiation.
    Bmp4, a member of the transforming growth factor-  superfamily, was
extensively studied during fetal lung development (45; 46). It was expressed
high in the distal tips of the fetal epithelium, but low in the adjacent
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mesenchyme. Over-expression of bmp4 in the lung distal epithelium led to the
inhibition of cell proliferation and epithelial hypoplasis (47). In the embryonic
epithelium culture, the addition of bmp4 reduced epithelial growth and
differentiation (48). However, in the intact lung explant organ culture, the
inclusion of bmp4 in culture medium was required for morphogenesis
branching and cell proliferation. A recent study demonstrated that Bmp4
up-regulated FGF7/10 receptor, and thus acted upstream of FGF signaling
pathway (49). However, another study showed that FGF7 (KGF)-MAPK and
TGF  signaling pathways were antagonized during AEC II proliferation and
differentiation in vivo and in vitro (50). In Fig. 5.7, Bmp4 plays a role for the
crosstalk between the two pathways. Up-regulations of Bmp4 expression were
detected in hyperoxia model (day 0 to day 1) and in cell culture model (day 3 to
day 5, coming back from decreased level). During the up-regulation phases,
KGF-MAPK signaling may be weakened by TGF  signaling, which should
promote AEC II switching to differentiation from proliferation. There was a
Bmp4 repression in cell culture model (AEC II to day 1), which was absent in
hyperoxia model. The meaning of Bmp4 repression is not clear from current
data.
Meox2 is a transcription factor of the homeobox family with a
helix-turn-helix motif, regulating cell proliferation, differentiation and migration.
Meox2 was also known as growth arrest-specific homeobox (Gax) and played
a role in the G0/G1 transition when quiescent cells reentered the cell cycle (51).
Meox2 was down-regulated in vascular smooth muscle cells following mitogen
activation in vitro and in vivo (52; 53). It inhibited cell proliferation in a
p21WAF/CIP-dependent manner (54). Over-expression of meox2 also inhibited
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cardiomyocyte proliferation (55). The deletion of meox2 led to defective
differentiation and morphogenesis of limb muscles (56). In the placenta,
meox2 may regulate the interaction of epithelial and mesenchymal cells (57).
Meox2 may have an inhibitory effect on the G0/G1 transition of the cell cycle,
and was down-regulated by ERK1/2-MAPK-p38  activation in vascular smooth
muscle cells (51). The ERK1/2-MAPK-p38  pathway can be activated by
growth factors like FGF7 (KGF) and IGF in AEC II. Therefore, the up-regulation
of Meox2 expression from day 0 to day 1 after hyperoxia exposure may
indicate the deactivation of ERK-MAPK signaling pathway induced by FGF or
IGF. With the up-regulation of Meox2, AEC II enter G1 phase of cell cycle
during recovery stages. In cell culture model, Meox2 expression was different
from hyperoxia model. It was down-regulated from day 0 to day 1, and
up-regulated from day 3 to day 5. The meaning of Meox2 expression changes
during cell culture is not clear from the present results.
Fdps is an enzyme in the isoprene biosynthetic pathway for the synthesis
of the cholesterol and nonsterol metabolites in the peroxisome (58). Fdps
played an important role in colon cancer proliferation (59), and prolonged the
activation of FGF-ERK-MAPK signaling by binding to FGF receptor (60). It has
dual roles in cell proliferation and differentiation by controlling lipid synthesis
and stabilizing FGF receptors. In hyperoxia recovery stage (day 0 to day 1),
increasing expression of Fdps may enhance AEC II proliferation through FGF
induced signaling pathways. Its expression levels were more complicated in
cell culture than in hyperoxia model. During cell attachment on plastic dishes,
its decreasing expression may repress cellular lipid synthesis. From day 3 to
day 5, the increasing Fdps expression may enhance lipid synthesis. The
140
down-regulation of Fdps from day 5 to day 7 may be resulted from the
confluence of cell in plastic dishes, in which cell should not proliferate or
synthesize lipid for plasma membrane.
 Rgc32 promotes cell proliferation by translocating to nuclei and
stimulating quiescent cells to enter into S-phase in aortic smooth muscle cells
upon complement activation (61; 62). In cytosol, it is a regulatory subunit of
M-phase promoting factor (MPF) for the G2/M phase transition. In nucleus, it
directly interacts with cyclin—dependent kinase p34cdc2 and is essential for
G1/S phase transition. Cdc2 inhibited ERK-MAPK signaling pathway during
mitosis through modulation of MEK1 (63). The down-regulation of Rgc32 in the
models of hyperoxia (day 0 to day 1) and cell culture (AEC II to day 1) may
reduce the inhibitory effect of cdc2 on cell proliferation through ERK-MAPK
pathways. Later, Rgc32 may have an inhibitory effect on AEC II proliferation as
it was up-regulated in both models (day 7 to normal AEC II level in hyperoxia,
and day 3 to day 5 in cell culture), possibly through Rgc32-cdc2 complex.
The above 5 genes appear to modulate MAPK signaling during AEC II
proliferation and differentiation. Dlk1 regulates IGF1 receptor, Bmp4 and Fdps
affect FGF receptor, and Rgc32 and Meox2 regulate and are regulated by
ERK1/2-MAPK signaling pathways, respectively. Since FGF7 (KGF) and IGF
have been well studied in AEC II, our results on the 5 genes indicate that there
are fine-tuning modulations on MAPK signaling pathway during AEC II
proliferation and differentiation.
The last gene, retnla, is a cytokine and may be involved in AEC II
proliferation and differentiation, but its cellular receptor or the mechanism is
unclear. In adipose tissue, retnla had an inhibitory effect on the differentiation
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of 3T3-L1 preadipocytes to adipocytes (64). Retnla in AEC II was also induced
in the bleomycin-induced pulmonary fibrosis model. Using co-cultures of AEC
II and fibroblasts, retnla was found to promote myofibroblast differentiation
independent of TGF-  (37). Additionally, retnla stimulates the proliferation of
pulmonary microvascular smooth muscle cells (65). Retnla was repressed in
both models of hyperoxia (A2 to day0, and day 1 to day 3) and cell culture (A2
to day 3), in which AEC II were activated for proliferation. The decreasing level
of Retnla may help AEC II enter cell proliferation status.  An increase of
Retnla during the initial recovery of AEC II after hyperoxia exposure may
indicate its role in promoting the differentiation of AEC II to AEC I through
cell-cell interaction (Fig. 5.7). No up-regulation of Retnla was detected during
cell culture. The possible reason is that the up-regulation of Retnla requires the
induction of adjacent AEC I as found in the lung but was absent in culture
dishes.
 The proposed model in Fig. 5.7 has three features. First, the 6 genes
play fine-tuning roles for AEC II proliferation and differentiation. These genes
modulate the components of MAPK and TGF  signaling pathways. The
modulation changes the effects of the pathway cascades, and indirectly tunes
the status of cell proliferation and differentiation. Second, the genes may have
promoting or inhibitory effects on AEC II depending on environment (in vivo
hyperoxia or in vitro cell culture) and time courses (hyperoxia exposure and
recovery, or cell isolation, attachment and culture). Consequently, the
expression levels of the 6 genes were not identical in both models. Cell culture
model always showed a down-regulation of gene expression for the first two
days, which may be resulted from cell isolation processes. Third, cell-cell
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communication or interaction plays a pivotal role in the proposed model.
Signaling molecules (IGF, FGF, Bmp4 and Retnla) secreted from adjacent cells
or AEC II itself directly stimulate or inhibit AEC II proliferation and
differentiation. Dlk1-Notch may induce AEC II differentiation through a direct
cell contact to form dlk1-notch signaling pathway. The adjacent cells may
determine AEC II differentiation. In hyperoxia model, the adjacent AEC I,
endothelial cell or macrophage may induce AEC II differentiation to a normal
AEC I. However, the adjacent AEC II in culture dish induce AEC II
trans-differentiation to AEC I-like cells.
 In summary, we identified 14 genes for AEC protection, apoptosis and
cell differentiation from rat model of hyperoxia exposure and recovery using
DNA microarray assays. Further study of these genes in cell culture model
indicated that 6 genes may be involved in AEC II proliferation and
differentiation. We proposed a model for AEC II differentiation, in which the 6
genes modulate MAPK and TGF  signaling pathways to fine-tune the balance
of AEC II proliferation and differentiation. Future studies on the 6 genes will
elucidate a high level understanding of AEC II differentiation through the
modulation and integration of MAPK, TGF  and other signaling pathways.
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Summary and Conclusion11
In this dissertation, a fine-tuning model of AEC differentiation is
proposed based on the results from experimental AEC differentiation models
using DNA microarray tools. Both experimental models and microarray tools
for gene expression profiling have been developed and tested in the five
chapters of this dissertation. It is the first time that a common mechanism
between AEC II differentiation models of in vivo hyperoxia and in vitro cell
culture is brought forth based on global gene expression profiles. The model
integrates the current knowledge of AEC II differentiation, known gene
functions, and the experimental data obtained from this dissertation, and thus
may serve a basis for future study of AEC II differentiation.
The fine-tuning model is based on two experimental models, and thus
may reflect the true mechanism of AEC II differentiation. For instance, there
were 14 genes differentially expressed during hyperoxia exposure and
recovery, and 6 of them were also changed during in vitro cell culture.
Therefore, the hyperoxia-specific genes or effects can be removed from the
fine-tuning model. The generality of the model can explain the dual roles of
many genes in other models of AEC differentiation. For instance, both
stimulatory and inhibitory effects of Bmp4 on AEC II differentiation were
observed during fetal lung development, and the respective mechanisms were
not known. The dual effects of Bmp4 on FGF-MAPK (activates cell proliferation)
11 Only the most relevant references are listed herein. All other references in this section can be found
in chapters 1~5.
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and TGF  (inhibits cell proliferation) signaling pathways in the fine-tuning
model can explain the dual roles of Bmp4 during fetal lung development.
Besides the generality, the fine-tuning model is novel. For instance, an
interesting result from the fine-tuning model is the role of Fdps in AEC
differentiation, which was not reported previously. The proposed model reveals
a novel cell differentiation function of a known check-point enzyme controlling
lipid synthesis. Therefore, this model substantially promotes the understanding
of AEC differentiation.
This fine-tuning model may be further improved. First, isolated AEC II
were used for gene expression profiling in both hyperoxia and cell culture
models, and thus cell isolation effects may affect the results. The relative
expression levels of the 6 common genes were down-regulated during the first
two days of cell culture. Possibly, the repression of some genes may be
resulted from cell isolation processes. A possible way to eliminate the cell
isolation is to utilize laser captured microdissection, by which AEC II can be
dissected from fixed lung tissue from normal or hyperoxia exposed rats (1).
These AEC II retain the snapshots of the original mRNA abundance and can
be used for global gene expression profiling without enzymatic cell isolation
effects. Second, it appears that hyperoxia exposure is a relative gentle
treatment that induces AEC proliferation and differentiation, since there are
only 50 genes showed detectable differential gene expressions.  The small
number of changed genes resulted in only 6 common genes. It is very possible
that there are more than 6 genes controlling AEC II differentiation. To identify
more genes, a stronger treatment may be utilized in the future. For instance,
the in vitro model, cultured AEC II, may be treated with hydrogen hyperoxide,
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which has a hyperoxia-like but stronger effect on cells.  An in vivo model, lung
tissues for neonatal rats may be cultured and treated with hydrogen
hyperoxide or growth factors, in which strong AEC proliferation may be
stimulated. With stronger treatments, more AEC II will be activated to enter cell
cycle, and thus more differentially expressed gene expression during cell
differentiation will be identified. Third, this fine-tuning model largely was based
on mRNA expression levels, and it should be verified at protein levels. In the
future study, high quality antibodies against the 6 genes should be generated
(dlk1 antibody has been tested), and thus the consistency of mRNA and
protein expression will be tested. Fourth, AEC II isolated from normal or
hyperoxia-exposed rats were used for gene expression profiling, and thus no
cells undergoing transition from “AEC I-like” to matured AEC I were used. An
improvement is to perform gene expression profiling of cultured AEC II from
day 1 to day 7, in which AEC II gradually trans-differentiate into AEC I-like cells.
Fifth, the proposed model may be functionally tested by gene knockdown.
Currently, no transgenic mouse is available for any of the 6 common genes.
Alternatively, one or more of the 6 genes may be silenced by RNA interference
technique, which selectively degrades the mRNA of target genes and lowers
the respective protein expression level (2). Having silenced one or more of the
6 genes, AEC II differentiation should be promoted or slowed down in some
stages, and thus the model can be tested. For instance, if Rgc32 is knocked
down by RNA interference, AEC II proliferation should stop or slow down at the
G1/S transition.
 Besides the fine-tuning model for AEC II differentiation, this
dissertation also provides new knowledge about lung and experimental tools,
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including the identified lung-prominent genes, AEC-specific genes and
functions, as well as improved AEC isolation methods and DNA microarray
tools. First, the identified genes in the lung or AEC shed light to the novel
functions of the target genes or cells. The 147 lung-prominent genes provide
clues of lung functions. For instance, MAPK13, a component of MAPK
signaling pathway, was not studied in the lung previously. Its predominant
expression in lung may indicate its role in stress and inflammatory responses.
A further localization of MAPK13 in specific cells of the lung will reveal the
physiological functions of the cells. At cellular level, the new AEC-markers may
reveal new functions of AEC I or AEC II. For instance, GABRP is a novel AEC
II marker (Chapter 1), which plays a role in the fluid clearance through the
regulation of chloride channels (unpublished data). Another example is ApoE
and transferrin (Chapter 4), which are expressed higher in AEC I and may
protect AEC I during hyperoxia exposure.  Second, the tools of AEC isolation
and DNA microarray can be used for more detailed investigation of AEC
differentiation or gene function study. For instance, DNA microarray can be
used to evaluate the specificity of RNA interference against a target gene (e.g.
Fdps). Further microarray hybridization also can identify down-stream genes
affected by the target gene, Fdps, and thus reveal the genes regulated by Fdps
or Fdps-MAPK pathway.
In summary, genes and pathways involved in type II cell proliferation
and differentiation were identified in this dissertation, including:
1. At organ level, 147 genes are expressed predominantly in lung, rather
than in heart, kidney, liver, spleen or brain by directly comparing
transcriptomes of the 6 organs.
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2. At cellular level, P2X7 and GABRP are potential AEC I and AEC II
markers. Among the 1080 AEC I- and 1142 AEC II-specific genes, two
AEC I-specific genes, Apo E and transferrin have protective effect
against oxidative stress during hyperoxia exposure.
3. During AEC II differentiation, 6 verified genes may be involved in a
regulatory network, which fine-tunes AEC II differentiation through
MAPK and TGF  pathways during in vivo hyperoxia exposure and
recovery and in vitro AEC culture.
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